TSS:Hg 35438.1

Basic information about the TSS

---

TSS ID: hg_35438.1 Species: human Chr: chr3		Start: 14125067 End: 14125098 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK027877 AK075010 Distance: 0 GeneID: 79188 HGNC/MGI_ID: HGNC:28472 UniProt_ID:

Gene_name: transmembrane protein 43 Gene_symbol: TMEM43 Gene_synonyms: DKFZp586G1919 LUMA MGC3222 Gene_source: HGNC:28472

TATA-Box annotation

---

Distance to TSS:	143
Nearest PromoterID:	NM_024334
Entrez ID:	79188
Nearest Unigene:	Hs.517817
Nearest Refseq:	NM_024334
Nearest Ensembl:	ENSG00000170876
Gene Name:	transmembrane protein 43
Gene Alias:	ARVC5|ARVD5|EDMD7|LUMA
Gene Description:	transmembrane protein 43
Gene Type:	protein-coding
CpG%:	0.095
GC%:	0.646766
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TMEM43 p2@TMEM43 p3@TMEM43 p4@TMEM43
Sample		p1@TMEM43	p2@TMEM43	p3@TMEM43	p4@TMEM43
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	2.73	9.74	12.08	6.04
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	6.07	13.56	14.77	6.47
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	5.21	11.57	16.20	6.56
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	3.74	12.89	13.72	5.20
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	5.85	11.02	13.72	2.70
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.56	12.99	12.79	3.68
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.23	16.78	14.60	6.97
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	5.09	10.42	12.11	7.51
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	5.13	10.26	12.82	6.41
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	6.96	12.17	10.43	5.22
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.08	12.53	10.51	4.04
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.91	7.72	10.57	5.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	5.32	7.58	10.16	9.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.62	6.77	10.52	12.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	7.68	6.37	10.10	12.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	6.04	7.04	11.07	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	4.59	6.12	9.83	9.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.33	6.75	11.39	8.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.40	11.73	9.06	9.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.22	8.73	6.47	12.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.82	8.02	7.89	8.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.25	9.67	8.63	10.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.66	7.63	7.63	9.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	6.31	6.79	9.46	8.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.29	9.03	10.84	7.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.86	7.28	9.18	7.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.14	8.24	7.14	8.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	9.67	8.02	9.43	13.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	6.30	8.40	8.56	10.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.42	8.69	9.95	11.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	8.79	5.23	9.42	9.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.18	7.42	9.38	9.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.07	8.86	7.39	6.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.24	8.41	10.39	10.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.79	8.79	9.16	10.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.13	6.52	8.81	10.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.74	6.95	8.99	10.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.27	7.46	9.07	8.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.64	5.40	7.83	10.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.00	6.72	8.88	9.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.71	5.18	9.41	7.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	6.59	7.61	7.47	7.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.96	9.49	8.22	13.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.17	6.29	6.99	8.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.64	7.23	7.03	12.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.68	8.14	9.54	10.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.24	4.80	6.72	9.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	6.26	5.36	10.13	10.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	5.51	10.05	7.90	9.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	5.86	5.26	8.09	8.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	7.58	9.43	9.22	11.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.56	10.23	10.90	12.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.16	8.87	11.00	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.29	8.62	10.94	11.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	13.42	4.19	9.23	13.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	7.35	7.81	8.27	8.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.48	9.08	9.40	12.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.39	4.82	9.96	9.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.12	7.54	11.94	18.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	3.53	9.17	7.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	5.61	5.05	9.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	4.78	11.15	12.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.81	6.46	8.15	12.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.77	9.75	13.00	12.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.68	12.42	12.07	10.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	16.16	32.33	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	0.00	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.85	10.73	10.73	12.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.43	9.92	13.88	10.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.44	10.79	11.73	16.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.96	5.96	16.89	16.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	2.78	5.88	9.59	11.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	3.36	9.78	12.23	8.56
Adipocyte - breast, donor1	11376-118A8	66.20	22.02	16.16	17.26
Adipocyte - breast, donor2	11327-117E4	30.96	17.33	13.80	13.64
Adipocyte - omental, donor1	11473-119C6	57.63	24.17	18.45	14.00
Adipocyte - omental, donor2	11474-119C7	45.60	20.93	23.92	17.19
Adipocyte - omental, donor3	11475-119C8	35.50	23.44	19.76	17.75
Adipocyte - perirenal, donor1	11476-119C9	38.92	14.04	33.18	17.23
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	5.50	5.50	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	31.16	17.61	9.03	6.77
Adipocyte - subcutaneous, donor3	11408-118E4	20.85	13.73	15.29	6.60
Adipocyte differentiation, day04, donor1	13019-139D4	23.08	18.97	9.58	11.73
Adipocyte differentiation, day04, donor2	13022-139D7	14.93	9.27	8.24	10.55
Adipocyte differentiation, day04, donor3	13025-139E1	24.25	17.56	8.92	15.61
Adipocyte differentiation, day04, donor4	13028-139E4	24.69	12.93	13.52	9.99
Adipocyte differentiation, day08, donor1	13020-139D5	16.89	9.97	7.16	9.73
Adipocyte differentiation, day08, donor2	13023-139D8	18.07	12.91	8.39	9.04
Adipocyte differentiation, day08, donor3	13026-139E2	27.73	6.40	4.80	6.93
Adipocyte differentiation, day08, donor4	13029-139E5	22.81	12.80	8.90	6.12
Adipocyte differentiation, day12, donor1	13021-139D6	19.96	12.48	6.24	13.31
Adipocyte differentiation, day12, donor2	13024-139D9	19.84	9.80	7.28	7.03
Adipocyte differentiation, day12, donor3	13027-139E3	15.38	10.14	5.89	7.20
Adipocyte differentiation, day12, donor4	13030-139E6	8.53	6.39	6.70	5.78
Alveolar Epithelial Cells, donor1	11510-119G7	6.63	10.61	9.50	9.72
Alveolar Epithelial Cells, donor2	11590-120G6	2.87	4.30	14.34	10.40
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	3.59	4.79	10.78
Amniotic Epithelial Cells, donor1	11533-120A3	16.55	25.73	21.23	16.01
Amniotic Epithelial Cells, donor2	11613-122A2	23.43	18.41	26.78	21.76
Amniotic Epithelial Cells, donor3	11694-123A2	13.76	25.89	21.16	17.46
Anulus Pulposus Cell, donor1	11248-116E6	36.27	16.71	12.82	9.73
Anulus Pulposus Cell, donor2	11463-119B5	23.27	19.59	21.80	15.67
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.73	9.88	6.29	16.62
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	13.46	9.99	4.34	13.46
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	8.56	8.56	17.12
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	13.75	8.67	6.58	14.05
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	8.85	7.59	8.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	8.58	6.60	5.28
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.29	8.45	10.40	10.72
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	8.74	5.83	8.74	14.08
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	7.72	3.56	7.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.07	7.91	7.53	10.55
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	11.61	13.79	6.53	11.61
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	5.02	5.02	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.33	10.71	9.23	9.06
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	9.55	9.55	12.28
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.52	6.03	9.05	7.69
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	11.79	8.04	8.57	9.11
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	12.47	9.26	9.26	11.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	15.50	5.61	8.29	6.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	7.80	8.78	6.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.78	7.80	7.30	12.44
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	4.80	13.21	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	14.16	7.08	10.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.58	9.43	8.23	13.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	8.39	8.39	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.02	11.65	9.71	9.22
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.62	6.07	6.83	12.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	15.75	4.85	7.27
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.39	10.26	7.98	10.26
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.47	7.91	8.34	11.12
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.10	6.45	9.03	8.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.57	6.10	8.91	11.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	12.54	7.72	6.43	8.36
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	8.56	9.99	9.99
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.70	9.36	8.77	10.53
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.94	8.13	11.44	13.55
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	5.94	16.63	11.88
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	8.65	9.66	10.17
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.68	9.68	9.93	13.24
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	10.17	6.35	6.99
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	16.40	8.63	8.63	10.36
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.74	7.83	6.77	13.55
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.28	7.25	6.96	7.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	22.67	7.56	12.28	11.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	12.04	7.12	8.31	11.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	6.95	9.27
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	6.34	2.11	8.45
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.51	8.15	8.79	10.94
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	9.02	7.22	7.82
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	6.56	3.64	14.58
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	11.03	9.43	7.13	11.49
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	2.55	7.65	12.75
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	14.49	7.37	5.59	6.61
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.72	10.12	6.81	11.77
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	10.71	8.26	10.40	7.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	11.95	10.52	6.21	13.86
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	10.87	13.30	7.32	8.65
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	7.63	12.21	7.63
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.29	10.52	4.98	8.31
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.59	11.39	8.74	12.45
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.54	8.36	7.27	6.18
Astrocyte - cerebellum, donor1	11500-119F6	19.90	8.84	19.04	12.16
Astrocyte - cerebellum, donor2	11580-120F5	13.86	15.06	23.45	17.29
Astrocyte - cerebellum, donor3	11661-122F5	22.86	10.28	13.63	9.86
Astrocyte - cerebral cortex, donor1	11235-116D2	14.64	7.32	9.41	11.50
Astrocyte - cerebral cortex, donor2	11316-117D2	6.96	9.38	12.94	17.47
Astrocyte - cerebral cortex, donor3	11392-118C6	7.76	11.49	11.93	12.08
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.46	1.72	5.85	13.53
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.88	2.38	5.14	12.65
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1.02	3.19	5.23	12.29
Basophils, donor1	12241-129G9	10.72	5.23	7.32	12.82
Basophils, donor2	12242-129H1	16.24	9.74	15.87	18.40
Basophils, donor3	12243-129H2	16.02	11.02	7.20	10.73
Bronchial Epithelial Cell, donor1	11511-119G8	9.27	16.17	19.40	13.80
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	4.11	15.09	5.03
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	21.52	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	0.63	8.79	10.04	12.55
Bronchial Epithelial Cell, donor5	11457-119A8	5.41	11.02	21.83	10.40
Bronchial Epithelial Cell, donor6	11461-119B3	3.68	14.05	21.19	16.12
Bronchial Epithelial Cell, donor7	11769-123I5	6.84	13.32	14.58	15.12
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.52	0.93	2.89	6.29
Burkitt's lymphoma cell line:RAJI	10476-106I8	2.10	4.66	6.06	9.32
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	8.31	9.59	15.35	18.87
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	10.34	31.03
CD14+ Monocytes, donor1	11224-116B9	12.96	4.51	3.94	6.76
CD14+ Monocytes, donor2	11305-117B9	8.35	10.58	7.98	6.68
CD14+ Monocytes, donor3	11381-118B4	10.98	10.76	9.66	9.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	7.36	3.40	3.40	5.38
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	7.58	5.31	1.90	9.48
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	4.60	3.29	0.99	4.60
CD14+ monocytes - mock treated, donor1	11863-125A9	26.74	19.37	17.63	20.82
CD14+ monocytes - mock treated, donor2	11873-125C1	16.90	12.67	14.18	14.18
CD14+ monocytes - mock treated, donor3	11883-125D2	25.82	23.69	21.08	22.03
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.05	11.22	6.70	9.21
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	12.42	10.49	9.94	10.21
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	17.85	8.18	8.18	12.40
CD14+ monocytes - treated with BCG, donor1	11860-125A6	10.77	7.24	5.68	7.83
CD14+ monocytes - treated with BCG, donor2	11870-125B7	12.11	8.37	5.34	9.08
CD14+ monocytes - treated with BCG, donor3	11880-125C8	18.72	6.09	5.01	9.14
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.94	8.43	3.04	4.21
CD14+ monocytes - treated with Candida, donor2	11878-125C6	14.26	7.39	5.81	5.81
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	9.98	3.33	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	16.36	13.39	9.82	11.90
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	15.56	9.98	8.98	14.37
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	16.86	10.83	7.91	11.87
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.73	9.15	9.38	11.44
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	15.83	6.79	4.75	3.39
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	12.66	10.04	6.11	5.67
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.06	9.41	6.19	10.49
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	14.48	13.78	10.12	12.56
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.46	13.05	17.67	17.67
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.92	4.41	4.78	6.06
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.34	4.58	2.82	9.16
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	8.77	9.65	4.39	8.77
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	8.54	6.97	4.53	6.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.15	9.29	5.58	7.81
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	13.80	8.41	4.10	9.05
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	10.24	7.78	5.73	6.96
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.91	4.64	4.87	5.79
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.62	5.10	6.03	8.58
CD14+CD16+ Monocytes, donor1	11789-124B7	6.76	5.01	6.76	9.81
CD14+CD16+ Monocytes, donor2	11801-124D1	10.86	6.01	4.62	9.93
CD14+CD16+ Monocytes, donor3	11912-125G4	13.00	6.07	5.20	8.66
CD14+CD16- Monocytes, donor1	11788-124B6	14.01	13.24	10.59	15.11
CD14+CD16- Monocytes, donor2	11799-124C8	21.83	14.84	9.43	14.67
CD14+CD16- Monocytes, donor3	11910-125G2	24.97	12.04	7.36	15.38
CD14-CD16+ Monocytes, donor1	11790-124B8	6.89	5.36	7.91	11.23
CD14-CD16+ Monocytes, donor2	11800-124C9	9.00	5.93	7.68	11.86
CD14-CD16+ Monocytes, donor3	11911-125G3	8.21	4.42	6.11	9.90
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	2.03	10.16	20.32
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.68	3.39	11.53	18.98
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1.04	2.07	9.32	21.75
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1.07	2.13	10.13	26.12
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.54	2.14	6.43	23.59
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	1.40	9.13	30.89
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	3.14	7.84	27.45
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	9.23	30.32
CD19+ B Cells, donor1	11544-120B5	1.64	2.47	4.93	18.90
CD19+ B Cells, donor2	11624-122B4	0.00	2.90	2.90	14.51
CD19+ B Cells, donor3	11705-123B4	1.51	1.51	8.08	18.68
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	1.62	3.64	9.29
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	5.19	5.99
CD34+ Progenitors, donor1	11545-120B6	1.00	7.03	7.03	15.06
CD34+ Progenitors, donor2	11625-122B5	4.49	6.74	11.80	12.36
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	4.88	7.52	11.27	25.18
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	7.44	6.76	15.33	19.17
CD4+ T Cells, donor1	11225-116C1	4.28	9.64	22.14	20.71
CD4+ T Cells, donor2	11306-117C1	4.90	12.25	22.66	23.88
CD4+ T Cells, donor3	11382-118B5	5.18	6.71	14.94	20.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.77	3.32	8.42	13.78
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.22	2.92	7.86	21.56
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.57	2.01	5.75	15.24
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.47	3.79	19.91	22.28
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1.40	0.70	16.15	26.69
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	0.00	9.89	19.78
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	1.45	1.45	9.54	16.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.85	0.51	9.15	14.57
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.97	1.29	11.77	14.19
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1.34	2.24	17.48	19.73
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1.05	2.80	14.32	24.46
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.88	4.84	10.56	22.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3.79	5.06	8.01	12.23
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.42	1.87	7.06	16.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2.00	1.67	5.01	18.71
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1.36	4.62	16.59	22.30
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1.07	2.14	15.54	26.26
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	5.38	10.76	16.14
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.93	3.52	9.46	17.99
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.43	2.82	6.93	19.71
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.84	1.89	5.67	19.33
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2.53	5.56	24.27	24.77
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.87	5.20	19.50	29.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	5.23	5.67	21.35	31.38
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.00	4.45	23.26	28.70
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.92	9.23	24.00	35.08
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	2.79	9.77	43.27
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	3.05	6.09	32.12	45.69
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.74	2.70	26.75	51.53
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	7.70	15.40	40.04
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	2.15	8.59	31.16	44.05
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	4.15	30.47	42.93
CD8+ T Cells, donor1	11226-116C2	8.51	26.19	23.57	23.57
CD8+ T Cells, donor2	11307-117C2	8.63	27.41	27.41	17.65
CD8+ T Cells, donor3	11383-118B6	5.81	16.16	22.72	14.90
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.96	6.65	10.09	8.26
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.07	5.03	6.71	6.71
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.47	5.20	10.67	3.56
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	8.11	10.51	11.41	9.61
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.96	3.36	9.36	6.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.37	6.14	7.28	7.50
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.48	6.95	6.74	10.21
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.16	7.11	7.63	5.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2.81	6.10	9.38	8.21
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.74	4.53	8.75	6.34
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.94	4.65	6.97	5.52
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.93	4.26	7.46	8.79
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	5.69	9.63	8.76	9.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	7.29	7.29	7.74	10.02
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	7.46	5.22	3.73	9.70
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.40	8.64	9.72	7.20
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.48	6.91	6.33	6.91
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.95	6.36	8.96	8.01
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.07	8.56	8.87	10.77
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.61	4.92	8.61	12.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.85	4.81	8.01	9.62
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.44	5.74	8.41	7.65
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.55	5.12	9.85	9.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.81	4.54	5.29	9.83
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.83	15.26	5.62	10.44
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	8.39	5.60	9.79	5.60
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	8.01	13.02	8.01	14.02
Cardiac Myocyte, donor1	11525-119I4	25.59	21.93	31.07	7.31
Cardiac Myocyte, donor2	11605-120I3	12.35	9.39	8.40	12.35
Cardiac Myocyte, donor3	11686-122I3	30.52	19.36	14.10	16.21
Chondrocyte - de diff, donor1	11261-116G1	80.77	37.44	26.35	16.64
Chondrocyte - de diff, donor2	11338-117F6	62.19	24.52	10.31	8.88
Chondrocyte - de diff, donor3	11410-118E6	46.08	25.26	15.47	12.86
Chondrocyte - re diff, donor2	11339-117F7	34.91	11.64	13.43	7.16
Chondrocyte - re diff, donor3	11411-118E7	15.77	16.58	18.60	15.37
Ciliary Epithelial Cells, donor1	11242-116D9	7.80	8.03	13.08	11.93
Ciliary Epithelial Cells, donor2	11323-117D9	7.70	8.12	10.69	11.54
Ciliary Epithelial Cells, donor3	11399-118D4	8.76	9.56	10.80	10.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.70	12.01	11.55	15.59
Corneal Epithelial Cells, donor1	11526-119I5	7.03	13.17	19.10	11.42
Corneal Epithelial Cells, donor2	11606-120I4	6.83	14.79	21.61	10.24
Corneal Epithelial Cells, donor3	11687-122I4	5.88	17.13	20.96	12.27
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	6.27	6.93	7.76	8.09
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	5.99	6.94	9.78	7.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	6.90	13.80	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	4.86	6.80	8.96	11.01
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.00	2.05	7.52	24.60
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1.31	1.31	7.83	14.36
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.48	0.00	5.32	23.71
Endothelial Cells - Aortic, donor0	11207-116A1	12.51	9.51	10.01	13.68
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	9.98	9.39	8.80
Endothelial Cells - Aortic, donor2	11340-117F8	14.42	11.31	9.33	10.75
Endothelial Cells - Aortic, donor3	11412-118E8	8.65	12.58	11.80	8.65
Endothelial Cells - Artery, donor1	11264-116G4	12.51	9.60	8.14	16.00
Endothelial Cells - Artery, donor2	11341-117F9	9.41	8.23	8.71	9.88
Endothelial Cells - Artery, donor3	11413-118E9	7.36	9.12	10.17	13.32
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.75	10.64	11.97	10.64
Endothelial Cells - Lymphatic, donor2	11317-117D3	9.74	9.43	7.00	15.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	18.04	7.89	7.89	15.50
Endothelial Cells - Microvascular, donor1	11265-116G5	20.50	11.59	11.89	9.81
Endothelial Cells - Microvascular, donor2	11342-117G1	10.41	5.73	8.33	8.85
Endothelial Cells - Microvascular, donor3	11414-118F1	12.76	6.24	5.39	11.20
Endothelial Cells - Thoracic, donor1	11266-116G6	23.21	14.00	18.41	14.40
Endothelial Cells - Thoracic, donor2	11343-117G2	11.53	11.53	10.48	11.01
Endothelial Cells - Umbilical vein, donor1	11243-116E1	17.27	10.31	10.44	11.93
Endothelial Cells - Umbilical vein, donor2	11324-117E1	8.26	7.17	8.47	11.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	6.23	8.06	10.99	13.07
Endothelial Cells - Vein, donor1	11267-116G7	7.96	10.24	6.83	15.93
Endothelial Cells - Vein, donor2	11344-117G3	9.08	4.19	5.59	6.29
Endothelial Cells - Vein, donor3	11416-118F3	9.42	7.22	10.52	12.87
Eosinophils, donor1	12244-129H3	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	11.55	16.50	34.66	47.86
Eosinophils, donor3	12246-129H5	10.70	7.13	17.83	53.50
Esophageal Epithelial Cells, donor1	11507-119G4	7.09	11.73	11.73	10.51
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	20.80	29.12	12.48
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.99	20.53	20.94	17.24
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.81	6.46	4.82	3.72
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.31	2.28	3.03	3.25
Fibroblast - Aortic Adventitial, donor1	11245-116E3	36.99	17.95	11.89	10.55
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	53.91	20.47	15.69	10.51
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.01	12.55	11.07	7.49
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	193.14	82.74	55.60	34.52
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.60	12.62	15.28	15.61
Fibroblast - Cardiac, donor1	11268-116G8	14.06	14.06	7.71	15.88
Fibroblast - Cardiac, donor2	11345-117G4	11.37	7.58	1.52	8.34
Fibroblast - Cardiac, donor3	11417-118F4	11.04	11.04	9.31	8.83
Fibroblast - Cardiac, donor4	11452-119A3	18.19	13.94	13.64	12.12
Fibroblast - Cardiac, donor5	11456-119A7	12.56	13.45	15.74	20.05
Fibroblast - Cardiac, donor6	11460-119B2	8.49	10.16	17.43	15.77
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.97	15.94	15.81	9.92
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.71	14.67	6.47	6.47
Fibroblast - Choroid Plexus, donor3	11653-122E6	4.39	17.58	5.86	8.79
Fibroblast - Conjunctival, donor1	11531-120A1	43.82	39.90	31.83	16.38
Fibroblast - Conjunctival, donor3	11692-122I9	47.15	23.41	17.47	12.04
Fibroblast - Dermal, donor1	11269-116G9	11.27	13.15	12.68	9.86
Fibroblast - Dermal, donor2	11346-117G5	11.32	12.74	10.38	8.02
Fibroblast - Dermal, donor3	11418-118F5	18.86	17.17	15.23	7.49
Fibroblast - Dermal, donor4	11450-119A1	6.56	13.90	25.10	16.39
Fibroblast - Dermal, donor5	11454-119A5	7.85	14.48	32.10	20.24
Fibroblast - Dermal, donor6	11458-119A9	5.36	15.76	28.26	18.52
Fibroblast - Gingival, donor1	11237-116D4	24.99	14.58	14.16	8.33
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	41.66	27.25	20.44	17.55
Fibroblast - Gingival, donor2	11318-117D4	7.78	8.57	14.76	14.63
Fibroblast - Gingival, donor3	11394-118C8	22.82	15.86	13.05	10.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	28.05	15.58	4.16	9.35
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.85	14.45	10.40	11.10
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	21.83	15.90	11.69	9.82
Fibroblast - Gingival, donor6 (control)	11922-125H5	15.96	12.31	13.12	8.93
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.12	7.76	14.47	12.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	17.40	12.28	14.92	11.70
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.82	13.77	15.82	11.59
Fibroblast - Gingival, donor8 (control)	11926-125H9	15.47	13.16	15.58	11.63
Fibroblast - Gingival, donor9 (control)	11927-125I1	29.93	16.73	14.23	14.23
Fibroblast - Lung, donor1	11270-116H1	5.44	9.52	12.23	9.52
Fibroblast - Lung, donor2	11347-117G6	19.40	13.43	17.91	14.92
Fibroblast - Lung, donor3	11419-118F6	10.76	8.65	11.61	12.45
Fibroblast - Lymphatic, donor1	11506-119G3	38.32	18.33	39.15	16.66
Fibroblast - Lymphatic, donor2	11586-120G2	22.38	25.18	36.36	15.38
Fibroblast - Lymphatic, donor3	11667-122G2	9.24	6.16	8.68	6.72
Fibroblast - Mammary, donor1	11540-120B1	20.30	17.05	25.17	20.70
Fibroblast - Mammary, donor2	11620-122A9	7.99	11.98	7.99	11.98
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	35.74	11.91
Fibroblast - Periodontal Ligament, donor1	11238-116D5	12.61	10.67	13.00	15.32
Fibroblast - Periodontal Ligament, donor2	11319-117D5	8.04	10.16	20.17	21.08
Fibroblast - Periodontal Ligament, donor3	11395-118C9	17.75	17.44	16.22	13.46
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.40	17.55	15.26	19.84
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.82	17.55	15.39	13.77
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.05	16.35	16.12	15.42
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.48	10.94	14.37	11.27
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	15.65	15.04	20.73	19.51
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	18.04	16.71	9.35
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	10.28	11.47	9.09	10.67
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	65.09	35.52	40.09	26.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	42.63	21.85	11.19	9.24
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	59.91	26.41	17.15	9.07
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	85.74	64.98	62.28	40.62
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	45.34	23.64	26.88	16.30
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	78.71	36.44	33.15	22.52
Fibroblast - skin normal, donor1	11553-120C5	57.43	22.81	15.42	13.78
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	80.00	50.53	33.89	29.68
Fibroblast - skin normal, donor2	11561-120D4	49.43	18.89	24.21	14.27
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	75.26	41.71	39.29	25.99
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	53.10	24.44	18.14	11.02
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	79.49	32.99	28.55	11.97
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	91.63	53.21	47.95	39.74
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	30.57	20.24	24.61	18.32
Fibroblast - skin walker warburg, donor1	11554-120C6	32.05	19.57	17.54	16.36
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	36.07	17.88	21.01	14.43
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	18.30	54.03	41.83	23.53
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	13.00	11.79	13.52	7.80
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	9.63	15.09	16.40	18.74
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6.90	13.54	10.22	13.54
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	2.30	3.83	10.72	4.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	3.83	4.47	6.38	7.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	2.57	8.27	8.56	12.84
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	2.21	4.41	7.72	8.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	5.02	8.68	8.68	10.96
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	2.18	5.55	8.72	12.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1.85	3.70	7.14	7.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	8.81	8.48	9.13	12.07
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.54	4.86	10.61	10.61
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1.70	4.66	6.92	8.34
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	2.09	6.16	6.65	9.36
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1.34	1.88	5.37	8.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	2.97	8.05	8.18	15.98
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	2.91	6.78	8.86	13.29
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	1.83	4.07	6.30	10.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	4.34	8.21	12.09	12.09
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	3.36	5.48	10.46	16.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	1.75	6.99	8.96	21.20
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	3.55	7.68	8.86	8.86
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	3.18	5.72	7.31	8.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	1.56	4.92	7.37	12.73
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	5.65	7.86	5.24	7.66
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	6.11	8.31	7.97	6.96
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	7.18	9.84	8.87	7.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	4.99	12.17	7.70	8.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5.64	7.51	6.32	7.86
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	4.09	8.30	5.42	7.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.99	8.99	8.99	7.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.33	8.17	7.35	8.37
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	4.13	7.84	7.63	7.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	4.38	8.30	7.26	8.99
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	5.50	8.17	7.00	7.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	4.41	9.04	7.94	8.82
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	4.55	9.96	7.50	9.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	5.84	7.29	6.65	8.43
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	3.21	7.70	8.98	10.90
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	4.74	8.53	6.16	6.63
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	3.80	6.33	5.54	7.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	6.08	8.82	6.69	8.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	4.29	10.35	8.05	7.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	3.07	6.81	7.46	6.59
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	4.21	7.29	7.29	9.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.59	10.18	7.78	6.94
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	7.49	7.22	4.81	6.69
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	6.43	8.87	6.12	8.11
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	5.31	8.42	5.83	5.70
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	2.71	6.78	4.07	6.51
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	6.64	8.85	6.64	7.93
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	6.80	8.33	6.58	5.26
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	6.94	9.92	4.96	7.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	6.86	8.71	7.39	7.78
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	7.47	10.09	7.06	10.09
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	10.17	15.50	13.22	9.66
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	0.60	3.98	8.96	11.15
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	0.31	3.54	5.08	10.48
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	0.61	4.09	6.55	8.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	2.50	5.01	5.01	5.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1.98	2.83	5.93	4.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	0.46	5.53	4.15	7.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	0.00	4.95	4.95	17.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1.93	4.25	7.74	9.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	6.42	4.81	9.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	0.00	6.96	6.96	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	3.91	4.88	6.51	7.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2.47	4.53	4.94	7.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	3.33	3.33	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	3.08	4.75	5.59	6.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1.63	4.90	4.90	9.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	3.36	5.03	5.87	6.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	3.50	4.13	4.77	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	3.06	3.74	3.06	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	0.00	2.09	4.18	12.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	2.86	5.73	3.44	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1.18	4.74	2.66	5.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	5.08	8.47	6.78	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	7.46	6.21	3.31	6.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	7.13	5.52	4.83	5.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	15.81	5.27	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	7.30	8.07	3.84	3.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	4.24	7.50	3.26	6.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1.34	5.35	5.35	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	4.24	7.32	2.31	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	18.83	15.06	5.14	10.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	2.48	2.48	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1.42	5.66	2.83	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	2.41	4.22	5.43	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	7.12	8.65	5.09	7.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	6.38	8.38	5.58	7.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	2.47	7.40	5.43	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	5.90	9.44	4.72	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	1.75	7.00	5.83	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1.32	3.95	3.95	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	0.85	9.32	3.39	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	5.97	7.16	4.78	6.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	6.31	7.28	2.43	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	12.55	3.42	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.40	9.56	8.32	7.07
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	12.37	9.00	15.74
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	38.69	18.71	10.15	11.10
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	26.74	10.44	11.28	9.19
Hep-2 cells mock treated, biol_rep1	11898-125E8	5.22	10.21	7.31	7.43
Hep-2 cells mock treated, biol_rep2	11899-125E9	6.58	10.47	7.76	4.39
Hep-2 cells mock treated, biol_rep3	11900-125F1	5.01	10.47	7.28	6.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	5.79	10.17	9.51	6.56
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	4.94	14.40	10.32	5.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	4.74	9.26	7.53	4.95
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	5.60	8.59	5.36	3.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	6.18	7.89	5.66	5.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	5.13	9.93	4.81	7.05
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	6.72	11.75	8.95
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	5.63	12.98	11.69
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	7.93	7.93	13.22
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	25.40	14.81	15.87	16.58
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	25.43	19.62	15.26	10.90
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	15.21	15.21	11.01	11.01
Hepatocyte, donor1	11523-119I2	8.47	2.42	2.42	1.21
Hepatocyte, donor2	11603-120I1	16.16	8.62	0.00	5.39
Hepatocyte, donor3	11684-122I1	8.59	1.84	3.68	4.29
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.31	5.87	8.48	13.05
Intestinal epithelial cells (polarized), donor1	11246-116E4	11.19	12.06	9.44	6.64
Iris Pigment Epithelial Cells, donor1	11530-119I9	8.92	9.88	9.19	15.50
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	6.37	6.37	15.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	13.35	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	2.77	4.15	8.31
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	2.50	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	15.38	10.25	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	4.87	21.12	14.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	6.67	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	10.89	3.63	18.15
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	6.62	3.97	10.59	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1.11	6.65	6.65	12.20
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	10.48	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.04	3.78	10.08	4.41
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	3.09	13.92	12.37
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	43.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.17	5.81	6.46	9.69
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	4.83	14.49	12.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	35.84	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.89	5.70	8.96	12.22
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.52	5.88	8.82	6.72
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.02	0.80	8.04	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2.77	5.54	6.46	13.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	30.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.30	5.66	5.19	9.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	3.63	7.26	9.07
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	29.48	44.23
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	5.38	12.91	17.22
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	7.62	13.98	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	16.43	49.29
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	6.38	12.12	5.74
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	5.47	10.94	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	15.80	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	7.14	12.14	13.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	6.64	19.91	16.59
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	62.55
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.62	6.79	9.26	5.56
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	3.51	8.78	15.80
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	9.43	9.43	15.72
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.70	3.48	11.82	9.74
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	8.85	11.07	13.28
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	3.24	3.24	9.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	5.23	4.36	6.98
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	4.50	4.50	9.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	10.45	6.97	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	8.53	5.33	9.60
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	2.77	13.85	5.54
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	2.85	11.40	19.95
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	5.52	12.89	8.28
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	3.03	6.05	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	18.63
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	1.06	8.46	1.06
Keratinocyte - epidermal, donor1	11272-116H3	10.04	11.42	14.52	6.85
Keratinocyte - epidermal, donor2	11349-117G8	4.69	7.61	7.03	4.69
Keratinocyte - epidermal, donor3	11421-118F8	5.87	13.44	15.52	11.26
Keratinocyte - oral, donor1	11251-116E9	7.15	19.53	33.83	22.36
Keratocytes, donor1	11527-119I6	52.61	46.76	29.57	16.85
Keratocytes, donor2	11607-120I5	12.89	14.06	12.89	9.37
Keratocytes, donor3	11688-122I5	17.19	25.89	19.36	11.66
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	8.79	19.78	41.76
Lens Epithelial Cells, donor1	11529-119I8	6.47	10.79	8.63	10.79
Lens Epithelial Cells, donor2	11609-120I7	6.92	7.84	11.42	17.76
Lens Epithelial Cells, donor3	11690-122I7	17.56	15.24	11.81	11.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.99	8.54	8.06	11.15
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	9.49	8.09	5.02	4.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.65	7.71	7.87	9.92
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.91	5.91	4.30	6.45
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.66	9.45	7.88	6.30
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.19	5.18	6.68	6.90
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.36	9.85	7.80	5.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.64	7.33	2.78	2.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.13	6.76	4.93	6.05
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	10.28	7.12	3.96	3.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.34	7.95	4.65	4.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	8.70	7.96	4.44	4.07
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.12	9.06	4.88	6.62
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.40	10.50	4.05	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.61	4.81	5.22	6.73
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.71	7.70	7.70	4.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.30	8.11	2.81	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.80	6.95	4.76	8.42
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.19	8.23	3.62	4.94
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.30	6.44	3.22	2.34
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.72	4.73	3.49	3.98
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	8.24	4.36	6.79
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.16	7.54	2.96	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	10.75	6.66	5.00	5.75
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.96	8.81	2.07	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.56	6.70	3.98	3.35
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.38	7.52	3.76	4.81
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	8.94	4.82	4.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.41	7.90	3.95	2.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.06	6.15	4.03	6.04
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.05	10.66	9.21	6.78
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.23	5.95	2.98	4.63
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.28	5.70	4.96	7.19
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	17.77	9.63	4.07	8.14
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	9.64	6.18	3.71	3.71
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.56	6.32	5.22	4.12
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.87	10.29	8.36	4.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.96	11.26	5.17	5.48
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.66	7.56	4.06	6.16
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.96	7.11	7.11	4.27
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	4.36	2.42	3.39
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.20	6.38	4.67	6.22
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.46	12.18	5.01	6.80
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	7.19	4.90	2.94
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.36	5.65	4.94	4.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	15.84	11.76	8.79	11.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.01	9.48	3.33	2.82
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.06	5.37	3.28	5.67
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	6.80	9.06	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	12.27	5.37	13.81
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.94	8.16	6.68	11.88
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	14.81	11.85	5.92	5.50
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	10.55	11.96	9.85	5.63
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	9.34	2.80	3.74	4.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	9.27	9.79	6.70	3.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	17.84	4.76	2.38	8.33
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	12.44	14.02	8.14	4.98
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.41	11.63	7.56	7.56
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	18.01	12.15	7.20	12.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.23	13.14	7.18	7.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	13.35	12.32	11.81	7.19
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	14.11	6.00	16.58
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.33	12.66	6.00	6.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	15.28	14.26	12.23	8.15
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.67	14.14	6.94	12.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	14.17	15.87	11.15	11.71
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.88	16.57	11.04	7.36
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	13.86	12.23	7.34
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	15.83	13.95	11.04	10.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.62	16.26	8.97	7.29
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	22.67	14.42	7.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	15.39	13.93	10.45	9.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	14.35	19.73	12.85	11.96
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.30	22.13	8.30	14.94
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.96	16.97	14.14	11.67
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.64	12.91	12.17	7.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	13.82	9.21	12.66
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	11.90	14.20	11.51	9.59
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.89	10.76	7.93	5.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	8.20	13.95	9.03	9.03
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.30	15.82	13.10	7.23
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	13.64	13.64	7.90	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	13.44	17.18	11.20	12.70
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.92	14.49	7.80	10.40
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	11.63	11.63	12.06	6.89
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	17.13	11.99	9.42
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.33	13.33	6.66	10.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.26	9.05	6.64	9.65
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.11	19.20	9.95	12.80
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.87	13.75	8.25	10.31
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	11.81	6.98	9.12
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	4.71	6.73	8.75	12.79
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.26	13.33	10.00	11.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	5.81	9.30	13.96	13.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	12.69	7.40	8.46
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	9.60	12.40	9.20	15.21
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.00	8.00	10.18	8.72
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	7.67	10.73	8.43
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	15.29	5.92	8.39
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	20.70	14.11	6.59	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.55	10.06	4.53	10.56
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	16.22	13.07	8.11	6.76
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	18.93	13.77	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	13.36	15.59	5.34	11.13
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	9.38	17.60	9.78	12.90
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.15	14.51	9.90	8.58
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	15.57	17.12	9.34	12.45
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.19	16.63	11.81	6.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	18.45	15.65	17.89	13.98
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	12.37	18.99	7.51	11.04
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	12.34	16.20	9.26	14.27
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	14.68	21.77	11.65	12.15
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.98	18.74	10.09	11.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	16.70	17.49	5.57	10.73
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	19.44	18.84	10.94	9.72
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.06	17.98	10.38	7.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	19.76	15.58	9.12	14.82
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	22.21	15.49	10.84	10.33
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.74	13.91	12.70	8.47
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	16.80	20.28	10.46	10.46
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	17.06	22.39	18.13	8.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	18.39	12.64	17.24	10.34
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13.37	20.06	14.40	10.28
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	17.68	27.59	13.44	12.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	17.02	15.89	15.89	10.78
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	11.23	20.39	10.82	8.74
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	15.66	12.53	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.70	15.45	14.61	9.19
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.98	19.98	10.22	10.22
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	17.40	18.73	13.38	9.37
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.64	26.20	16.57	10.69
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.74	18.18	11.72	9.29
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	6.42	15.60	11.93	8.26
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	18.67	17.78	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	10.26	17.10	17.10	13.68
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	10.74	15.34	15.34	11.50
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14.23	16.42	19.70	12.04
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	11.14	12.03	16.93	15.59
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.44	18.72	12.48	8.06
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	15.91	17.90	5.97
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	16.63	10.39	12.47
Macrophage - monocyte derived, donor1	11232-116C8	4.79	3.19	4.79	5.93
Macrophage - monocyte derived, donor2	11313-117C8	9.18	8.99	13.03	11.19
Macrophage - monocyte derived, donor3	11389-118C3	6.55	6.29	9.57	8.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	8.50	12.21	9.03	11.68
Mallassez-derived cells, donor2	11929-125I3	15.05	12.83	15.69	16.32
Mallassez-derived cells, donor3	11930-125I4	11.67	9.45	13.90	13.90
Mammary Epithelial Cell, donor1	11273-116H4	22.42	26.21	23.02	14.65
Mammary Epithelial Cell, donor2	11350-117G9	16.79	15.64	11.58	8.11
Mammary Epithelial Cell, donor3	11422-118F9	1.00	7.98	10.23	7.48
Mast cell - stimulated, donor1	11487-119E2	13.56	10.85	8.81	10.85
Mast cell, donor1	11563-120D6	5.19	4.00	2.92	12.76
Mast cell, donor2	11565-120D8	22.59	25.26	16.34	44.87
Mast cell, donor3	11566-120D9	31.52	32.42	23.41	31.29
Mast cell, donor4	11567-120E1	20.92	23.22	17.20	36.88
Mast cell, expanded and stimulated, donor5	11940-126A5	4.32	3.55	5.32	19.30
Mast cell, expanded and stimulated, donor8	11942-126A7	11.09	7.00	15.18	15.18
Mast cell, expanded, donor5	11939-126A4	5.05	2.41	4.82	12.85
Mast cell, expanded, donor8	11941-126A6	4.69	2.68	4.35	9.04
Melanocyte - dark, donor1	11502-119F8	13.33	8.26	4.28	9.05
Melanocyte - dark, donor2	11582-120F7	12.11	9.34	11.42	12.46
Melanocyte - dark, donor3	11663-122F7	11.88	8.77	4.93	5.29
Melanocyte - light, donor1	11274-116H5	8.93	4.47	3.76	3.29
Melanocyte - light, donor2	11351-117H1	10.24	4.09	2.73	3.41
Melanocyte - light, donor3	11423-118G1	6.94	5.20	6.94	3.47
Melanocyte, donor1 (MC+1)	12641-134G4	10.52	11.66	6.98	5.41
Melanocyte, donor2 (MC+2)	12739-135I3	11.56	9.14	10.22	5.65
Melanocyte, donor3 (MC+3)	12837-137B2	9.11	8.30	5.62	3.48
Meningeal Cells, donor1	11493-119E8	12.03	14.02	24.44	19.73
Meningeal Cells, donor2	11573-120E7	10.12	15.41	23.77	14.52
Meningeal Cells, donor3	11654-122E7	7.42	10.68	12.06	7.01
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	8.84	9.70	12.55	13.69
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	17.41	12.18	6.84	5.64
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	6.57	3.94	6.57
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	7.85	7.85	13.08
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.02	9.33	8.61	7.18
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.57	13.13	9.32	9.11
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.08	7.54	12.06	9.55
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.31	9.01	9.23	12.09
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	7.31	16.07	10.96
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.12	7.57	10.23	12.28
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	24.38	11.91	15.51	10.39
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	12.64	13.01	2.60	7.43
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.05	17.89	16.58	11.18
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	17.51	8.61	4.75	4.45
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	7.01	7.01	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.89	12.81	12.17	12.17
Mesenchymal stem cells - adipose, donor0	11217-116B2	7.44	13.47	14.89	13.82
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.08	18.45	13.76	13.45
Mesenchymal stem cells - umbilical, donor0	11214-116A8	8.71	10.89	7.26	8.71
Mesothelial Cells, donor1	11247-116E5	6.36	6.63	6.89	10.34
Mesothelial Cells, donor2	12156-128G5	9.51	3.00	4.50	7.01
Mesothelial Cells, donor3	11402-118D7	7.59	6.79	5.85	5.71
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	2.70	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	4.43	6.90	6.16	11.08
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.07	8.24	10.01	9.13
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	4.03	3.10	4.96	6.82
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.77	4.36	7.47	8.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	4.63	6.95
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6.26	6.51	8.01	12.51
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	7.45	7.45	8.38	10.24
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.08	4.67	6.91	12.19
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.34	5.54	9.50	9.50
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	2.65	0.88	7.08
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.12	6.84	9.50	11.02
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	2.63	1.32	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.82	4.67	3.82	7.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	2.76	7.37	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.58	2.98	5.37	7.15
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	1.68	6.71	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	5.77	3.01	3.26	7.78
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.80	4.99	5.70	6.42
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.55	1.11	2.21	3.32
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.45	3.68	4.60	6.91
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.63	3.58	5.89	9.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.89	3.06	5.50	6.52
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.87	4.51	2.79	7.51
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.89	4.00	6.89	6.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.04	2.19	2.63	7.23
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.55	5.58	6.08	6.08
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	4.97	1.66	6.63
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.44	6.25	4.62	8.70
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.71	4.71	5.88	6.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	0.00	2.18	4.36
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.73	7.21	2.88	6.25
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.00	4.80	5.60	4.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	2.74	4.11	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	5.51	7.01	6.01	5.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	2.04	6.12	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.63	4.38	7.44	9.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	3.31	3.31	7.73
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	4.48	5.12	6.40
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.69	7.44	6.20	9.92
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	3.48	4.18	5.57
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	8.84
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.28	4.10	5.47	10.94
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	2.63	1.31	3.50	6.56
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.78	2.84	2.13	4.97
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.42	5.89	5.33	10.10
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.42	4.57	2.91	4.99
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.58	3.50	0.58	5.83
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	5.43	3.32	2.11	11.46
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.59	5.01	5.43	7.93
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2.77	1.85	1.85	3.69
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.14	2.28	3.98	14.80
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.42	1.93	2.63	6.63
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.44	2.33	5.18	10.37
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	2.57	4.72	3.43	11.58
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.64	1.91	3.18	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.74	2.94	5.07	6.94
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	4.49	5.99	5.09	9.88
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	2.54	1.70	2.97	3.67
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.60	1.91	5.10	12.42
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2.65	3.76	5.53	10.17
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.90	3.41	1.90	6.45
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.11	2.84	2.56	6.53
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	3.69	2.46	4.92	10.32
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	2.61	3.26	3.26
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.00	2.65	3.53	6.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	5.48	6.05	5.77	8.36
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	4.95	2.47	2.06	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.06	1.79	2.38	3.28
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	5.35	3.56	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1.97	3.29	4.60	7.23
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	8.42	5.26	10.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.12	2.97	3.36	6.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	7.45	5.59	9.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.51	4.13	4.13	5.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.59	10.12	16.78	16.25
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.71	2.71	2.94	5.54
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.16	2.95	2.21	5.89
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.03	2.20	2.56	4.76
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	9.33	6.22	21.78
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.41	3.21	3.74	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	1.01	4.04	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.32	5.90	5.48	7.59
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	4.09	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	1.27	0.00	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.81	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	4.53	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	0.00	3.26	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	35.33	18.96	11.42	13.36
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.56	14.11	17.77	15.16
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	9.34	8.01	12.68	5.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.50	4.17	6.26	9.60
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	9.89	8.56	15.59	20.16
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	9.58	9.58	15.96
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	4.76	6.80	4.76
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	5.51	3.68	11.03
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.04	5.44	5.44	5.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.90	11.39	12.78	9.76
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.73	7.57	7.03	6.22
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.51	9.67	9.04	11.14
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.37	8.44	8.93	5.46
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.35	7.85	9.74	9.74
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.52	6.35	8.16	8.84
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.08	10.61	10.12	5.88
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	18.77	9.48	8.20	11.48
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	22.28	9.55	11.67	5.30
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	11.41	10.21	6.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.07	7.22	10.50	10.83
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.38	7.48	9.76	8.29
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	23.11	8.64	6.17	8.82
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	9.14	9.85	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.45	11.49	14.71	6.44
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.39	7.71	8.68	9.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	22.76	9.31	11.38	10.35
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	20.23	12.64	17.70
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.05	10.92	7.35	6.91
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.40	8.89	10.16	6.77
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.89	11.63	14.00	11.16
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.60	13.31	12.02	7.30
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	18.06	18.06	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.00	7.33	5.33	7.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.66	7.21	8.12	2.71
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	12.30	8.33	12.30	3.57
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	11.14	21.36	12.07
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.51	11.73	12.49	14.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.62	9.12	10.10	7.17
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	7.84	6.10	6.97
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.28	7.69	8.14	6.33
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	4.41	11.46	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	34.57	9.31	9.31	7.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	19.84	11.41	7.94	9.42
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.80	8.42	9.19	8.04
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	36.60	15.73	22.99	17.84
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.45	9.28	6.41	7.51
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.94	11.52	7.45	6.78
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	5.11	10.22	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.34	10.97	5.49	5.49
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.07	5.67	9.13	8.50
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.55	11.80	8.47	4.54
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.03	11.08	6.33	6.33
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	36.28	11.34	10.20	18.14
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	10.12	5.06	10.12
Myoblast, donor1	11241-116D8	21.86	10.06	9.44	7.33
Myoblast, donor2	11322-117D8	20.90	14.38	12.85	12.27
Myoblast, donor3	11398-118D3	17.66	10.09	8.58	11.44
NK T cell leukemia cell line:KHYG-1	10777-110G3	4.09	4.82	7.15	12.11
Natural Killer Cells, donor1	11230-116C6	8.61	18.14	19.07	23.06
Natural Killer Cells, donor2	11311-117C6	11.46	21.41	28.04	14.47
Natural Killer Cells, donor3	11387-118C1	11.23	15.46	20.43	18.04
Neural stem cells, donor1	11275-116H6	31.58	6.90	8.71	6.53
Neural stem cells, donor2	11352-117H2	9.63	13.48	11.55	30.81
Neurons, donor1	11494-119E9	15.93	15.93	18.21	27.31
Neurons, donor2	11574-120E8	5.06	6.38	11.23	20.48
Neurons, donor3	11655-122E8	8.22	9.87	14.80	27.13
Neutrophils, donor1	11233-116C9	7.42	12.99	29.70	35.26
Neutrophils, donor2	11314-117C9	8.70	2.90	20.29	17.39
Neutrophils, donor3	11390-118C4	5.50	15.88	29.93	73.91
Nucleus Pulposus Cell, donor1	11252-116F1	53.79	28.50	18.76	12.11
Nucleus Pulposus Cell, donor2	11409-118E5	17.26	9.44	8.79	6.19
Nucleus Pulposus Cell, donor3	11462-119B4	16.04	11.63	18.45	7.82
Olfactory epithelial cells, donor1	11933-125I7	23.40	16.24	15.00	9.22
Olfactory epithelial cells, donor2	11934-125I8	24.03	20.55	17.22	11.58
Olfactory epithelial cells, donor3	11935-125I9	21.45	22.36	21.23	12.37
Olfactory epithelial cells, donor4	11936-126A1	27.95	23.96	22.50	13.83
Oligodendrocyte - precursors, donor1	11496-119F2	7.82	9.63	9.63	17.45
Osteoblast - differentiated, donor1	11276-116H7	28.50	11.06	7.87	8.51
Osteoblast - differentiated, donor2	11353-117H3	17.15	10.29	8.00	11.43
Osteoblast - differentiated, donor3	11425-118G3	22.35	15.52	11.79	10.55
Osteoblast, donor1	11277-116H8	21.69	15.63	12.31	10.36
Osteoblast, donor2	11354-117H4	17.56	18.26	8.43	16.15
Osteoblast, donor3	11426-118G4	21.68	20.44	17.95	19.02
Pancreatic stromal cells, donor1	11249-116E7	30.07	20.97	18.95	17.02
Pericytes, donor1	11491-119E6	8.68	7.68	11.24	10.01
Pericytes, donor2	11571-120E5	8.83	8.15	14.94	11.77
Pericytes, donor3	11652-122E5	13.02	14.65	18.51	14.24
Perineurial Cells, donor1	11499-119F5	15.71	17.63	11.87	16.95
Perineurial Cells, donor2	11579-120F4	12.05	11.78	14.08	16.75
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	7.01	6.06	6.37	15.62
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	8.57	6.61	11.02	10.53
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	4.92	6.60	12.04	14.37
Placental Epithelial Cells, donor1	11278-116H9	10.76	26.79	17.22	12.68
Placental Epithelial Cells, donor2	11355-117H5	21.07	22.18	15.52	8.87
Placental Epithelial Cells, donor3	11427-118G5	12.37	21.40	14.33	14.72
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	26.58	10.76	15.82	11.71
Preadipocyte - breast, donor1	11467-119B9	74.28	19.70	10.50	9.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	46.34	25.32	16.71	21.54
Preadipocyte - breast, donor2	11328-117E5	41.65	26.12	16.89	16.89
Preadipocyte - omental, donor1	11468-119C1	61.70	20.14	17.05	9.38
Preadipocyte - omental, donor2	11329-117E6	60.67	24.44	16.15	16.15
Preadipocyte - omental, donor3	11403-118D8	32.23	25.50	20.34	15.04
Preadipocyte - perirenal, donor1	11469-119C2	48.23	21.65	24.61	19.69
Preadipocyte - subcutaneous, donor1	11279-116I1	16.28	7.37	5.84	5.84
Preadipocyte - subcutaneous, donor2	11356-117H6	12.40	13.99	13.99	13.10
Preadipocyte - subcutaneous, donor3	11428-118G6	17.88	11.24	10.56	7.15
Preadipocyte - visceral, donor1	11280-116I2	21.61	15.56	12.76	9.87
Preadipocyte - visceral, donor2	11357-117H7	19.79	9.20	9.66	7.36
Preadipocyte - visceral, donor3	11429-118G7	11.39	12.85	14.73	10.24
Prostate Epithelial Cells (polarized), donor1	11253-116F2	12.07	16.90	9.35	7.39
Prostate Epithelial Cells, donor2	11331-117E8	7.18	8.94	11.37	11.92
Prostate Epithelial Cells, donor3	11404-118D9	2.20	10.53	13.72	9.06
Prostate Stromal Cells, donor1	11254-116F3	35.65	21.64	18.79	10.82
Prostate Stromal Cells, donor2	11332-117E9	26.54	23.85	12.37	11.30
Prostate Stromal Cells, donor3	11405-118E1	24.82	15.64	10.64	8.34
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.38	5.84	12.04	8.39
Renal Cortical Epithelial Cells, donor2	11596-120H3	2.29	4.02	8.04	7.83
Renal Epithelial Cells, donor1	11517-119H5	3.04	4.06	9.64	7.61
Renal Epithelial Cells, donor2	11597-120H4	3.56	4.27	8.54	6.40
Renal Epithelial Cells, donor3	11678-122H4	3.39	4.55	8.58	8.26
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.89	8.85	17.02	21.11
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.14	10.24	18.60	13.07
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.65	9.32	12.21	17.54
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	6.65	7.32	5.99
Renal Mesangial Cells, donor1	11518-119H6	12.32	8.80	13.21	8.14
Renal Mesangial Cells, donor2	11598-120H5	8.15	12.54	19.44	18.18
Renal Mesangial Cells, donor3	11679-122H5	5.27	8.04	7.77	8.60
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	5.37	5.64	10.74	11.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.95	5.90	10.54	8.86
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	4.05	6.94	8.87	14.66
Retinal Pigment Epithelial Cells, donor0	11215-116A9	1.81	3.89	9.07	7.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	10.23	8.53	10.80
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	3.09	12.35	6.17
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.53	7.78	9.03	6.02
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.25	15.64	9.62	13.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	8.93	4.47	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	5.50	9.36	7.15	6.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	4.64	8.70	1.74	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	4.94	3.25	5.85	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	3.48	6.75	5.56	5.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	6.02	7.58	5.69	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	4.59	8.81	8.43	10.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	4.31	5.01	5.01	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	5.78	6.93	4.85	5.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	4.79	5.89	7.39	7.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	4.08	5.75	5.60	4.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	3.94	5.02	5.20	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	7.17	6.74	8.03	8.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	3.65	6.12	5.90	4.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	7.08	5.97	3.76	4.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.16	4.78	5.93	4.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	4.75	5.68	5.59	4.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	5.26	5.45	4.89	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	4.64	5.84	6.64	7.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	4.67	5.35	5.65	4.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	5.54	6.49	3.82	3.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	5.87	6.19	8.01	5.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	3.64	4.20	6.45	5.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	3.93	7.18	5.30	3.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	4.74	5.11	6.20	8.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	4.29	6.62	5.76	4.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	5.37	7.66	5.91	5.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	6.37	6.37	9.43	7.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	4.96	5.75	5.16	5.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	6.31	6.31	6.31	4.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	4.56	6.84	6.01	9.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.97	5.31	5.09	4.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	7.31	6.27	6.27	3.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	6.46	7.94	9.29	6.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	3.75	6.98	5.62	4.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	5.21	8.10	7.13	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	5.33	9.11	8.77	8.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	2.19	5.49	7.13	4.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	3.94	5.75	8.37	4.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	3.41	5.28	5.79	7.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	3.85	5.33	5.47	5.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	2.13	4.26	4.53	5.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	4.42	4.98	5.67	5.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	1.90	4.05	3.81	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	5.44	7.86	3.63	5.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	4.05	5.18	5.09	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	4.19	6.29	6.29	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	3.32	6.04	3.93	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	4.16	5.51	8.20	7.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	10.63	8.73	6.55	5.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	5.48	6.08	7.91	7.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	4.22	8.14	5.73	6.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	7.24	11.54	8.37	6.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	6.29	7.49	11.08	11.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.32	10.98	9.56	8.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	6.62	11.10	11.31	10.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	1.80	6.01	7.21	7.21
Schwann Cells, donor1	11498-119F4	5.45	11.85	16.55	16.17
Schwann Cells, donor2	11578-120F3	6.80	3.40	3.40	10.21
Schwann Cells, donor3	11659-122F3	5.04	6.57	7.45	13.36
Sebocyte, donor1	11220-116B5	8.22	17.53	16.43	20.27
Sebocyte, donor2	11301-117B5	10.57	19.76	15.62	7.35
Sebocyte, donor3	11378-118B1	7.21	9.69	9.48	7.83
Sertoli Cells, donor1	11255-116F4	49.70	19.88	19.88	23.19
Sertoli Cells, donor2	11333-117F1	48.01	25.42	14.12	11.30
Skeletal Muscle Cells, donor1	11281-116I3	19.53	17.86	13.99	9.85
Skeletal Muscle Cells, donor2	11358-117H8	8.67	6.51	7.23	3.61
Skeletal Muscle Cells, donor3	11430-118G8	10.03	7.52	17.56	20.90
Skeletal Muscle Cells, donor4	11451-119A2	7.70	13.51	21.99	16.49
Skeletal Muscle Cells, donor5	11455-119A6	8.92	11.30	20.22	15.61
Skeletal Muscle Cells, donor6	11459-119B1	5.85	9.85	20.01	13.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	16.00	13.61	15.25	16.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.41	13.56	20.26	15.41
Skeletal Muscle Satellite Cells, donor3	11397-118D2	9.13	9.82	17.36	14.78
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	25.02	12.89	8.85	7.33
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	15.92	17.37	8.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.07	13.48	18.85	11.70
Skin - palm, donor1	10286-104F7	40.29	59.09	72.52	18.80
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	2.45	4.47	6.78	5.48
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	36.81	21.27	24.54	20.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	2.86	3.76	7.27	7.01
Small Airway Epithelial Cells, donor1	11256-116F5	10.29	15.15	15.57	8.90
Small Airway Epithelial Cells, donor2	11334-117F2	5.63	9.71	11.53	16.32
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	19.45	26.22	25.37	38.27
Small Airway Epithelial Cells, donor3	11406-118E2	3.15	10.34	13.87	11.92
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.70	2.16	5.55	3.09
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	72.26	38.69	33.13	27.35
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	10.58	7.05	4.70
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.67	12.15	9.28	7.07
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.54	9.06	7.09	7.48
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.09	3.09	9.27	12.36
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	12.01	9.01	11.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.70	11.18	8.78	8.38
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	18.18	18.18	12.63	10.64
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.99	14.72	16.26	11.91
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	7.81	9.77	12.70	8.14
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.63	11.81	12.40	9.16
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.26	7.40	11.67	9.11
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.74	9.27	11.71	10.09
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	19.18	18.87	12.18	12.79
Smooth Muscle Cells - Carotid, donor1	11285-116I7	23.74	17.68	10.36	5.56
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	12.24	12.24	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	6.68	13.35	6.68
Smooth Muscle Cells - Colonic, donor1	11239-116D6	7.37	8.85	10.47	9.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.98	9.26	11.19	12.05
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.60	11.23	13.54	12.80
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	17.48	9.28	7.73	6.19
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	6.47	18.32	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.77	11.95	11.95	12.25
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.56	12.97	10.24	8.53
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	16.02	13.04	15.78	12.80
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.92	8.45	5.74	3.32
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	40.96	20.93	13.88	15.25
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	26.57	14.49	14.49	7.25
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	13.78	16.43	12.45	10.60
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.44	16.64	15.71	12.92
Smooth Muscle Cells - Prostate, donor2	11335-117F3	26.42	15.15	11.27	10.27
Smooth Muscle Cells - Prostate, donor3	11465-119B7	21.05	9.64	6.09	8.62
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.62	15.53	11.31	7.09
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	22.51	9.75	10.50	15.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	0.00	5.17	7.75	11.63
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.53	10.70	9.77	5.58
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	21.71	17.17	14.14	10.60
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.10	14.42	17.86	13.48
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	19.76	12.98	12.39	11.50
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	14.75	13.00	13.41	15.41
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	19.15	13.08	10.74	12.15
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.38	9.35	6.76	7.48
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.92	9.43	10.20	16.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.59	15.42	16.36	12.03
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	11.32	8.66	6.71	15.79
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	22.87	21.53	15.92	16.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	1.43	2.86	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	14.68	10.28	11.01	10.77
Smooth Muscle Cells - Uterine, donor1	11258-116F7	29.17	14.14	13.04	7.73
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.66	5.27	8.19	9.66
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	29.74	13.41	6.61	9.13
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	23.01	11.11	9.52	5.55
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	30.50	7.81	6.32	6.32
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.97	7.19	6.83	6.83
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.91	9.37	9.37	10.22
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	17.33	11.03	16.54	18.51
Smooth muscle cells - airway, control, donor1	11966-126D4	25.65	10.92	6.86	5.33
Smooth muscle cells - airway, control, donor2	11967-126D5	13.18	10.38	5.59	4.39
Smooth muscle cells - airway, control, donor3	11968-126D6	32.60	7.11	5.85	5.02
Smooth muscle cells - airway, control, donor4	11969-126D7	44.00	11.00	7.79	11.92
Synoviocyte, donor1	11291-117A4	41.74	20.03	15.32	8.58
Synoviocyte, donor2	11368-117I9	81.13	33.02	19.44	14.42
Synoviocyte, donor3	11440-118H9	50.49	32.39	27.03	17.65
Trabecular Meshwork Cells, donor1	11532-120A2	18.58	17.51	20.37	20.73
Trabecular Meshwork Cells, donor2	11612-122A1	29.73	21.80	7.93	7.93
Trabecular Meshwork Cells, donor3	11693-123A1	8.57	11.58	12.97	10.19
Tracheal Epithelial Cells, donor1	11292-117A5	5.38	8.24	10.75	7.67
Tracheal Epithelial Cells, donor2	11369-118A1	3.48	7.73	11.60	7.73
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	16.03	18.33	8.02
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	22.88	15.87	12.30	13.16
Urethra, donor2	10319-105A4	16.19	19.78	25.18	28.77
Urothelial Cells, donor1	11520-119H8	8.77	9.30	11.16	12.75
Urothelial Cells, donor2	11600-120H7	4.41	10.82	14.42	13.22
Urothelial Cells, donor3	11681-122H7	1.83	11.46	13.52	10.31
Urothelial cells, donor0	11216-116B1	4.46	8.47	15.16	17.16
Whole blood (ribopure), donor090309, donation1	12179-129A1	6.23	14.24	43.60	55.17
Whole blood (ribopure), donor090309, donation2	12180-129A2	12.87	22.87	42.89	64.33
Whole blood (ribopure), donor090309, donation3	12181-129A3	3.42	11.64	28.07	37.65
Whole blood (ribopure), donor090325, donation1	12176-128I7	5.17	7.92	18.25	38.91
Whole blood (ribopure), donor090325, donation2	12177-128I8	6.39	11.04	15.11	27.31
Whole blood (ribopure), donor090612, donation1	12182-129A4	4.16	6.25	42.69	41.65
Whole blood (ribopure), donor090612, donation2	12183-129A5	6.42	13.77	33.04	54.15
Whole blood (ribopure), donor090612, donation3	12184-129A6	2.74	14.61	21.91	47.47
Wilms' tumor cell line:G-401	10809-111A8	2.96	10.36	13.08	11.23
Wilms' tumor cell line:HFWT	10597-108E3	2.64	20.24	28.16	15.84
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.61	10.06	13.97	8.66
achilles tendon, donor2	10292-104G4	12.40	18.60	8.27	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1.02	3.57	7.39	11.47
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.23	1.86	7.20	12.31
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.83	1.07	2.14	6.77
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	1.90	1.90	10.07	14.42
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	6.18	12.65	21.08	20.24
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	9.31	6.77	10.57	12.05
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	4.90	3.27	6.26	9.53
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	7.49	7.49	11.02	10.13
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	3.68	6.94	14.70	21.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	2.33	2.33	6.99	18.64
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2.94	3.68	10.49	10.49
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	3.90	7.80	11.70
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	4.42	8.13	6.74	9.06
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2.59	4.92	11.91	15.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	3.21	4.09	11.40	11.69
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	6.04	7.44	8.37	13.01
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	6.58	5.76	6.58	6.58
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.23	2.15	2.76	2.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	8.11	6.40	3.84	6.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	5.76	6.67	6.07	8.49
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	7.22	7.22	5.54	6.98
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.67	4.68	9.80	6.46
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	4.00	8.01	8.67	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	9.29	11.15	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	4.14	6.40	11.68	11.30
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	8.29	4.80	6.11	6.11
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	3.75	3.75	22.49	15.00
adenocarcinoma cell line:IM95m	10796-110I4	7.30	8.48	7.54	9.42
adipose tissue, adult, pool1	10010-101C1	31.18	15.36	13.19	17.53
adipose, donor1	10184-103D4	1.17	3.52	6.45	17.01
adipose, donor2	10185-103D5	4.46	12.17	8.92	6.08
adipose, donor3	10186-103D6	5.72	9.26	6.26	10.07
adipose, donor4	10187-103D7	0.87	3.47	6.07	6.07
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1.10	4.73	5.37	10.26
adrenal gland, adult, pool1	10081-102A9	7.28	10.91	0.00	14.55
adult T-cell leukemia cell line:ATN-1	10421-106C7	3.74	9.34	24.41	31.62
alveolar cell carcinoma cell line:SW 1573	10708-109H6	6.79	10.00	16.44	16.79
amniotic membrane cells, donor1	12235-129G3	28.75	66.77	45.44	35.24
amniotic membrane cells, donor2	12236-129G4	9.47	14.88	12.17	13.86
amniotic membrane cells, donor3	12237-129G5	25.34	97.51	104.29	59.21
amygdala - adult, donor10196	10167-103B5	3.56	1.19	3.56	16.60
amygdala, adult, donor10252	10151-102I7	1.22	5.27	15.21	29.20
amygdala, newborn, donor10223	10360-105E9	6.46	8.07	8.07	10.33
anaplastic carcinoma cell line:8305C	10428-106D5	27.25	18.97	12.61	10.82
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	2.21	9.05	20.96	23.83
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	27.39	21.38	9.02	7.35
aorta, adult, pool1	10052-101G7	43.35	32.95	34.13	37.46
appendix, adult	10189-103D9	7.37	7.76	13.58	15.91
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	5.50	8.60	5.85	6.53
artery, adult	10190-103E1	17.66	12.23	13.59	14.95
astrocytoma cell line:TM-31	10425-106D2	6.52	10.29	9.85	7.39
b cell line:RPMI1788	10427-106D4	1.78	3.87	8.18	10.71
basal cell carcinoma cell line:TE 354.T	10702-109G9	27.47	20.25	16.09	14.15
bile duct carcinoma cell line:HuCCT1	10432-106D9	3.67	6.25	4.17	5.85
bile duct carcinoma cell line:TFK-1	10496-107C1	5.19	10.38	9.71	8.87
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3.91	10.63	8.39	11.18
bladder, adult, pool1	10011-101C2	23.03	14.78	14.99	18.25
blood, adult, pool1	10053-101G8	4.43	11.07	11.07	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	13.70	14.56	11.13	11.13
bone marrow, adult	10192-103E3	16.87	9.45	4.05	7.42
brain, adult, donor1	10084-102B3	3.08	3.08	9.23	12.30
brain, adult, pool1	10012-101C3	2.90	4.23	5.01	11.25
brain, fetal, pool1	10085-102B4	2.67	5.34	5.34	16.03
breast carcinoma cell line:MCF7	10482-107A5	33.04	27.42	16.85	7.60
breast carcinoma cell line:MDA-MB-453	10419-106C5	3.12	3.37	9.61	12.61
breast, adult, donor1	10080-102A8	14.52	20.83	17.05	29.04
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	5.97	15.88	10.67	13.97
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	5.26	12.06	16.70	12.68
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.22	9.67	12.66	16.58
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.36	13.31	9.68	6.05
carcinoid cell line:NCI-H1770	10703-109H1	0.47	3.29	3.29	4.70
carcinoid cell line:NCI-H727	10735-110B6	6.23	7.44	7.11	8.42
carcinoid cell line:SK-PN-DW	10719-109I8	1.58	4.75	13.63	10.77
carcinosarcoma cell line:JHUCS-1	10642-109A3	10.11	15.17	10.65	6.39
caudate nucleus - adult, donor10196	10177-103C6	2.30	3.45	6.91	23.03
caudate nucleus, adult, donor10252	10164-103B2	2.18	2.84	15.06	28.95
caudate nucleus, adult, donor10258	10379-105H1	2.29	3.06	7.64	14.52
caudate nucleus, newborn, donor10223	10354-105E3	12.09	4.39	10.25	13.55
cerebellum - adult, donor10196	10173-103C2	11.65	23.31	20.39	34.96
cerebellum, adult, donor10252	10166-103B4	5.12	8.97	24.98	38.22
cerebellum, adult, pool1	10083-102B2	2.41	5.86	9.31	9.66
cerebellum, newborn, donor10223	10357-105E6	12.45	12.45	22.42	17.44
cerebral meninges, adult	10188-103D8	3.03	5.29	7.56	12.10
cerebrospinal fluid, donor2	10294-104G6	5.85	6.58	0.00	2.92
cervical cancer cell line:D98-AH2	10552-107I3	14.09	15.38	6.90	3.59
cervical cancer cell line:ME-180	10553-107I4	12.59	24.86	16.74	10.44
cervix, adult, pool1	10013-101C4	36.54	19.95	19.74	26.77
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	39.99	32.19	21.74	22.29
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	7.84	13.06	18.29
choriocarcinoma cell line:BeWo	10423-106C9	7.58	10.81	6.09	5.84
choriocarcinoma cell line:SCH	10785-110H2	5.30	13.80	11.71	13.18
choriocarcinoma cell line:T3M-3	10618-108G6	11.38	17.08	11.62	11.38
chorionic membrane cells, donor1	12238-129G6	25.64	43.02	24.22	23.93
chorionic membrane cells, donor2	12239-129G7	13.72	16.21	10.84	13.92
chorionic membrane cells, donor3	12240-129G8	32.42	48.90	34.07	28.57
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	2.02	6.06	5.05
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	3.46	6.53	13.64	12.10
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.55	8.03	13.09	11.19
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1.28	2.05	4.62	6.16
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1.94	3.39	7.74	8.22
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1.22	3.26	7.53	9.98
chronic myelogenous leukemia cell line:K562	10454-106G4	5.01	9.42	15.61	8.83
chronic myelogenous leukemia cell line:KU812	10409-106B4	6.26	10.69	17.20	8.08
clear cell carcinoma cell line:JHOC-5	10638-108I8	3.66	10.29	9.37	16.92
clear cell carcinoma cell line:TEN	10636-108I6	11.10	6.25	5.03	4.68
colon carcinoma cell line:CACO-2	10513-107D9	8.79	7.87	5.86	5.67
colon carcinoma cell line:COLO-320	10420-106C6	6.46	8.36	8.74	6.84
colon, adult, donor1	10082-102B1	9.52	8.33	10.71	19.04
colon, adult, pool1	10014-101C5	18.92	10.11	11.52	15.86
colon, fetal, donor1	10070-101I7	7.42	8.03	11.74	14.21
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58	18.33	27.50
common myeloid progenitor CMP, donor2	12134-128E1	25.04	50.07	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.62	9.77	6.37	14.45
cord blood derived cell line:COBL-a 24h infection	10453-106G3	7.55	6.94	9.66	10.26
cord blood derived cell line:COBL-a untreated	10449-106F8	5.50	6.20	9.73	8.32
corpus callosum, adult, pool1	10042-101F6	10.17	7.63	6.63	24.77
cruciate ligament, donor2	10295-104G7	12.16	13.78	19.45	13.78
diaphragm, fetal, donor1	10069-101I6	25.68	15.25	10.43	11.24
diencephalon, adult	10193-103E4	3.60	3.36	3.12	14.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.46	0.69	2.30	4.13
ductal cell carcinoma cell line:KLM-1	10438-106E6	28.72	21.03	10.51	3.33
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	14.92	13.96	14.68	5.30
ductus deferens, adult	10196-103E7	13.46	9.97	6.98	11.46
duodenum, fetal, donor1, tech_rep1	10071-101I8	5.76	14.40	5.76	14.40
duodenum, fetal, donor1, tech_rep2	10071-101I8	17.66	8.83	16.18	6.62
dura mater, adult, donor1	10041-101F5	63.18	21.06	12.22	9.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.66	9.10	6.44	5.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	3.44	7.74	10.75	4.73
embryonic pancreas cell line:1B2C6	10604-108F1	11.72	19.12	19.73	11.72
embryonic pancreas cell line:1C3D3	10605-108F2	9.99	18.77	14.53	11.81
embryonic pancreas cell line:1C3IKEI	10606-108F3	9.88	18.22	15.44	19.14
embryonic pancreas cell line:2C6	10603-108E9	6.57	19.70	17.08	24.96
endometrial carcinoma cell line:OMC-2	10497-107C2	9.72	29.16	36.54	23.46
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	14.32	9.79	4.89	13.77
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.11	8.20	6.91	5.95
epidermoid carcinoma cell line:A431	10426-106D3	9.56	10.78	12.45	5.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	21.89	19.25	11.33	6.05
epididymis, adult	10197-103E8	20.72	12.35	14.23	14.02
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	51.63	44.88	28.39	20.05
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	10.62	18.48	17.70	6.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	4.06	16.38	9.44	12.58
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	7.09	18.31	13.58	13.88
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	6.50	17.48	13.56	14.45
esophagus, adult, pool1	10015-101C6	21.66	16.35	20.60	17.31
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	16.78	37.07	30.18	12.02
eye - muscle inferior rectus, donor1	10272-104E2	14.49	16.90	21.73	16.90
eye - muscle lateral, donor2	10298-104H1	8.42	14.73	8.42	12.63
eye - muscle medial, donor2	10299-104H2	5.95	20.84	7.44	11.91
eye - muscle superior, donor2	10297-104G9	5.73	16.05	6.88	13.76
eye - vitreous humor, donor1	10268-104D7	1.46	4.37	5.83	2.91
eye, fetal, donor1	10054-101G9	22.12	13.98	11.19	18.30
fibrosarcoma cell line:HT-1080	10758-110E2	12.44	14.23	16.03	9.87
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	4.99	9.97	15.91	11.87
frontal lobe, adult, pool1	10040-101F4	4.69	4.22	6.10	10.51
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	6.00	16.81	15.91	9.31
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	11.06	14.63	15.00	15.45
gall bladder, adult	10198-103E9	18.35	10.14	11.11	16.42
gamma delta positive T cells, donor1	11937-126A2	1.61	8.59	11.81	39.19
gamma delta positive T cells, donor2	11938-126A3	1.49	3.36	16.81	32.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	35.27	77.94	52.80	24.29
gastric adenocarcinoma cell line:MKN45	10612-108F9	7.93	15.67	12.57	15.47
gastric cancer cell line:AZ521	10549-107H9	9.67	10.17	4.26	7.21
gastric cancer cell line:GSS	10560-108A2	2.75	5.49	8.24	10.07
gastrointestinal carcinoma cell line:ECC12	10615-108G3	8.45	9.82	6.85	8.22
giant cell carcinoma cell line:LU65	10487-107B1	5.62	6.20	6.77	7.46
giant cell carcinoma cell line:Lu99B	10433-106E1	10.78	15.12	17.21	14.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	3.74	8.98	6.24	8.48
glioblastoma cell line:A172, tech_rep1	10444-106F3	24.07	13.19	9.18	13.09
glioblastoma cell line:A172, tech_rep2	10444-106F3	24.44	14.47	9.13	12.22
glioblastoma cell line:T98G	10485-107A8	18.54	11.48	7.62	7.06
glioma cell line:GI-1	10413-106B8	21.09	19.04	12.30	9.96
globus pallidus - adult, donor10196	10175-103C4	0.00	4.37	5.83	10.93
globus pallidus, adult, donor10252	10161-103A8	2.93	6.83	13.43	34.91
globus pallidus, adult, donor10258	10367-105F7	1.37	4.11	15.06	16.43
globus pallidus, newborn, donor10223	10364-105F4	4.26	9.59	3.20	7.99
granulocyte macrophage progenitor, donor1	12131-128D7	14.68	2.45	17.13	22.02
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	21.86	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	17.60	16.00	16.00	15.36
hIPS +CCl2, biol_rep1	14383-156B9	0.46	2.75	5.05	12.86
hIPS +CCl2, biol_rep2	14384-156C1	0.46	5.03	4.12	5.94
hIPS +CCl2, biol_rep3	14385-156C2	2.58	3.22	1.29	8.37
hIPS, biol_rep1	14380-156B6	0.00	0.00	1.44	1.44
hIPS, biol_rep2	14381-156B7	0.69	2.06	2.06	6.86
hIPS, biol_rep3	14382-156B8	3.31	1.10	5.52	9.93
hairy cell leukemia cell line:Mo	10712-109I1	4.02	6.61	8.33	13.79
heart - mitral valve, adult	10205-103F7	39.16	22.72	11.66	18.83
heart - pulmonic valve, adult	10206-103F8	28.50	10.98	15.69	15.17
heart - tricuspid valve, adult	10207-103F9	19.98	31.64	29.98	21.65
heart, adult, diseased post-infarction, donor1	10050-101G5	10.20	12.65	14.69	16.32
heart, adult, diseased, donor1	10051-101G6	8.94	12.35	17.03	25.12
heart, adult, pool1	10016-101C7	10.81	6.44	7.82	13.57
heart, fetal, pool1	10046-101G1	18.48	12.12	12.32	14.99
hepatic mesenchymal tumor cell line:LI90	10778-110G4	11.11	8.33	12.03	13.88
hepatoblastoma cell line:HuH-6	10633-108I3	5.95	11.89	9.51	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	8.40	19.67	15.03	13.59
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	9.47	20.03	18.33	17.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	8.69	20.82	18.39	13.14
hepatoma cell line:Li-7	10484-107A7	6.45	8.45	8.12	7.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	2.71	2.81	3.22	3.52
hippocampus - adult, donor10196	10169-103B7	1.89	4.73	9.46	17.98
hippocampus, adult, donor10252	10153-102I9	2.86	4.29	13.47	27.15
hippocampus, adult, donor10258	10374-105G5	1.49	2.49	3.49	11.95
hippocampus, newborn, donor10223	10363-105F3	1.41	3.52	6.70	6.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1.83	7.32	13.43	11.60
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	3.53	6.48	5.11	7.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.06	4.57	11.17	5.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	2.26	1.69	6.20	5.64
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1.55	3.10	7.23	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.31	6.07	3.80	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	10.51	11.68	10.22	10.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.31	11.20	7.97	9.26
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	11.26	8.34	8.76	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	13.02	13.02	8.76	12.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	7.39	10.61	10.13	11.73
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	7.41	9.43	6.73	10.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1.25	5.32	5.48	8.61
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.98	4.91	6.88	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3.49	5.24	4.36	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	2.29	4.39	6.49	6.30
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	0.87	6.98	5.23	7.85
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1.00	10.99	10.00	9.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.46	9.23	8.48	6.03
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	3.64	7.73	4.09	6.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.01	8.46	6.26	5.01
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.10	17.15	11.43	8.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.06	16.26	8.13	6.97
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	12.26	11.36	14.65	5.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	3.88	4.62	7.39	6.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	3.42	8.84	6.56	7.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1.63	7.76	11.02	9.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	5.63	4.93	5.28	7.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	4.75	3.80	3.48	7.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1.82	3.93	5.14	7.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	7.76	10.34	6.72	12.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	8.63	8.63	5.98	8.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.44	12.31	8.47	6.16
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	14.32	11.25	11.50	8.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	14.39	11.36	9.09	11.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.07	13.78	10.42	7.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	2.17	4.11	8.21	8.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1.78	3.57	8.91	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	4.39	4.88	5.37	8.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	3.67	4.89	5.20	5.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	6.51	9.76	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2.32	4.30	7.28	6.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	7.11	8.76	4.93	10.40
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5.43	5.43	9.41	10.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	8.90	9.25	8.19	6.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	13.13	4.77	11.93	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	13.54	13.27	9.34	11.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	6.47	6.73	10.24	6.73
immature langerhans cells, donor1	11904-125F5	24.21	8.96	6.05	7.02
immature langerhans cells, donor2	11905-125F6	26.14	25.35	39.61	13.47
insula, adult, pool1	10039-101F3	5.20	4.35	9.56	13.34
keratoacanthoma cell line:HKA-1	10791-110H8	4.55	18.53	16.91	10.40
kidney, adult, pool1	10017-101C8	19.22	9.51	9.01	9.01
kidney, fetal, pool1	10045-101F9	15.07	12.17	11.39	11.81
large cell lung carcinoma cell line:IA-LM	10509-107D5	26.27	41.90	27.55	16.62
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.25	6.64	3.73	7.05
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	14.13	27.52	19.08	14.13
left atrium, adult, donor1	10079-102A7	9.26	8.17	11.99	15.80
left ventricle, adult, donor1	10078-102A6	11.12	14.16	18.20	17.70
leiomyoblastoma cell line:G-402	10721-110A1	5.20	10.67	11.22	13.13
leiomyoma cell line:10964C	10569-108B2	26.23	12.93	17.96	7.54
leiomyoma cell line:15242A	10570-108B3	22.83	9.24	9.78	7.61
leiomyoma cell line:15425	10571-108B4	19.43	14.33	14.81	13.11
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70	12.70	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	12.55	8.36	10.46
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	20.07	21.01	21.01	10.39
liposarcoma cell line:KMLS-1	10782-110G8	8.28	9.69	12.97	10.31
liposarcoma cell line:SW 872	10726-110A6	11.94	17.79	13.65	13.40
liver, adult, pool1	10018-101C9	12.48	8.75	3.08	4.05
liver, fetal, pool1	10086-102B5	2.82	4.70	1.88	4.70
locus coeruleus - adult, donor10196	10182-103D2	3.21	5.54	8.75	13.42
locus coeruleus, adult, donor10252	10165-103B3	1.11	4.24	10.70	21.22
locus coeruleus, adult, donor10258	10375-105G6	2.82	2.54	4.80	10.16
locus coeruleus, newborn, donor10223	10362-105F2	9.67	7.15	12.20	13.04
lung adenocarcinoma cell line:A549	10499-107C4	5.95	7.06	2.91	4.57
lung adenocarcinoma cell line:PC-14	10408-106B3	6.89	12.41	11.72	6.20
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	4.75	9.23	10.94	8.83
lung, adult, pool1	10019-101D1	14.18	12.64	12.76	16.77
lung, fetal, donor1	10068-101I5	41.38	18.55	23.12	25.40
lung, right lower lobe, adult, donor1	10075-102A3	8.25	11.00	10.08	20.16
lymph node, adult, donor1	10077-102A5	6.63	7.10	11.36	16.09
lymphangiectasia cell line:DS-1	10727-110A7	0.66	4.38	8.55	16.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.15	0.45	0.75	3.47
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	33.98	39.93	16.14	7.65
mature adipocyte, donor1	12231-129F8	33.74	12.88	13.76	13.32
mature adipocyte, donor2	12232-129F9	44.00	16.19	8.30	9.96
mature adipocyte, donor3	12233-129G1	67.80	21.10	13.51	7.82
mature adipocyte, donor4	12234-129G2	44.48	8.95	10.27	6.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	7.39	7.62	5.00	6.67
medial frontal gyrus - adult, donor10196	10170-103B8	1.13	2.26	12.41	15.79
medial frontal gyrus, adult, donor10252	10150-102I6	1.29	4.05	10.85	25.93
medial frontal gyrus, adult, donor10258	10368-105F8	0.32	2.22	4.45	16.20
medial frontal gyrus, newborn, donor10223	10352-105E1	7.25	5.97	9.38	8.96
medial temporal gyrus - adult, donor10196	10183-103D3	0.84	3.04	8.94	11.98
medial temporal gyrus, adult, donor10252	10156-103A3	1.49	5.73	12.31	22.92
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	0.00	1.93	15.41
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	3.59	3.95	12.20	11.84
medulla oblongata - adult, donor10196	10174-103C3	6.49	5.19	5.19	20.12
medulla oblongata, adult, donor10252	10155-103A2	3.87	5.88	10.84	21.05
medulla oblongata, adult, pool1	10038-101F2	10.20	6.20	5.55	15.26
medulla oblongata, newborn, donor10223	10361-105F1	7.64	10.07	11.46	11.11
medulloblastoma cell line:D283 Med	10838-111E1	9.30	16.38	8.86	8.64
medulloblastoma cell line:ONS-76	10759-110E3	6.48	11.13	11.13	8.80
melanoma cell line:COLO 679	10514-107E1	15.52	13.37	4.46	3.16
melanoma cell line:G-361	10465-106H6	24.70	29.59	16.02	13.57
meningioma cell line:HKBMM	10691-109F7	4.52	9.41	13.93	18.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	4.41	1.76	12.34	17.62
merkel cell carcinoma cell line:MS-1	10844-111E7	1.04	8.04	17.37	16.33
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.74	12.27	13.35	15.65
mesenchymal precursor cell - adipose, donor2	11748-123G2	13.09	12.00	14.72	10.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.22	17.81	18.22	12.42
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.91	7.73	10.54	12.78
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.68	12.52	13.09	15.79
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	28.46	17.35	9.02	9.02
mesenchymal precursor cell - cardiac, donor1	11752-123G6	26.26	12.36	12.19	11.16
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.22	14.61	16.56	11.96
mesenchymal precursor cell - cardiac, donor3	11754-123G8	15.78	11.41	13.66	18.17
mesenchymal precursor cell - cardiac, donor4	11755-123G9	9.45	9.45	11.34	14.04
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	7.40	8.82	12.80	18.21
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.16	13.50	7.90	9.55
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.10	8.58	13.56	13.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	11.17	10.82	7.33	11.52
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	8.98	11.02	13.47	19.80
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.99	11.14	7.19	8.99
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.21	8.17	10.76	14.79
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.73	8.44	10.72	6.84
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.85	13.85	18.46	24.33
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.21	7.02	11.51	13.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.82	11.82	16.19	19.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.94	8.10	9.20	8.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.89	8.58	8.58	12.59
mesenchymal stem cell line:Hu5/E18	10568-108B1	18.95	10.10	11.79	8.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.99	14.61	10.96	11.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	41.18	18.42	11.25	9.21
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	38.74	15.18	10.99	9.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	36.97	14.79	12.32	12.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	35.07	12.94	8.94	8.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	46.03	19.29	10.49	9.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.51	17.68	16.50	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	45.88	18.07	10.19	7.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	47.30	18.46	12.40	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	52.43	17.85	14.95	12.27
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	49.75	16.34	12.74	12.02
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	44.00	16.13	13.20	14.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	42.96	18.80	11.41	7.38
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	45.03	17.19	16.38	11.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	49.40	17.61	12.03	7.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	19.14	10.94	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	15.49	15.49	15.49
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	48.39	23.06	14.62	11.04
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	40.74	18.91	23.28	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	48.51	24.52	12.79	12.79
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	48.25	13.90	10.63	11.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	48.59	17.10	13.99	12.05
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	52.47	25.18	8.39	12.59
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	50.67	15.90	15.90	7.95
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	4.77	4.77	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	39.14	19.57	13.05	7.71
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	54.83	24.37	10.97	8.53
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	27.05	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	57.64	22.17	17.10	10.13
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	54.15	18.62	13.45	9.66
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	51.58	17.19	15.04	15.04
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	3.99	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	27.55	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	32.19	14.26	6.52	10.19
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	25.42	8.74	10.33	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	24.17	7.66	9.43	10.02
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	28.99	9.66	9.97	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	33.42	18.71	8.02	10.69
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	39.03	13.01	7.10	8.28
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	23.11	10.27	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	29.60	11.70	17.21	12.39
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.86	7.42	4.95	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	3.36	5.61	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	18.45	6.36	2.54	5.09
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.48	7.25	6.04	3.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	4.36	2.18	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	7.60	5.07	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.68	5.46	7.28	9.10
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	4.52	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.88	11.53	7.41	9.88
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	34.92	9.72	7.54	6.75
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	30.50	8.44	10.71	9.09
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	33.61	12.22	6.11	4.07
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.80	10.06	6.19	5.42
mesothelioma cell line:ACC-MESO-1	10493-107B7	2.83	9.92	14.17	17.48
mesothelioma cell line:ACC-MESO-4	10494-107B8	41.70	32.90	25.02	15.06
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	17.09	4.27	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.30	13.97	9.76	6.58
mesothelioma cell line:Mero-25	10850-111F4	51.75	44.26	21.33	12.03
mesothelioma cell line:Mero-41	10851-111F5	48.90	31.78	23.47	15.40
mesothelioma cell line:Mero-48a	10852-111F6	20.37	16.83	10.63	13.29
mesothelioma cell line:Mero-82	10853-111F7	19.18	31.01	21.81	16.29
mesothelioma cell line:Mero-83	10854-111F8	49.36	42.56	24.51	13.62
mesothelioma cell line:Mero-84	10855-111F9	15.42	17.69	18.20	7.08
mesothelioma cell line:Mero-95	10856-111G1	31.68	18.01	13.25	4.97
mesothelioma cell line:NCI-H2052	10847-111F1	12.59	10.60	7.95	6.96
mesothelioma cell line:NCI-H226	10846-111E9	28.05	18.64	15.02	7.96
mesothelioma cell line:NCI-H2452	10848-111F2	12.13	13.32	12.30	8.37
mesothelioma cell line:NCI-H28	10845-111E8	7.13	8.91	17.30	21.38
mesothelioma cell line:No36	10857-111G2	22.83	24.79	15.66	6.85
mesothelioma cell line:ONE58	10858-111G3	21.13	15.44	10.30	6.77
migratory langerhans cells, donor1	11901-125F2	3.84	5.37	10.94	11.90
migratory langerhans cells, donor2	11902-125F3	2.32	4.03	5.98	12.21
migratory langerhans cells, donor3	11903-125F4	3.41	4.31	7.00	8.79
mixed mullerian tumor cell line:HTMMT	10689-109F5	10.12	26.44	14.69	7.51
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.17	14.84	17.17	11.66
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	8.06	12.21	10.83	8.98
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	5.14	3.81	5.52	10.09
myelodysplastic syndrome cell line:SKM-1	10772-110F7	6.47	9.24	8.87	10.35
myeloma cell line:PCM6	10474-106I6	6.33	11.66	11.66	22.34
myxofibrosarcoma cell line:MFH-ino	10600-108E6	29.42	32.97	29.42	22.32
myxofibrosarcoma cell line:NMFH-1	10684-109E9	13.73	11.18	9.61	16.67
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.68	16.60	15.49	9.69
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.22	14.49	17.72	9.63
nasal epithelial cells, donor2	12227-129F4	9.38	17.66	15.46	16.01
neuroblastoma cell line:CHP-134	10508-107D4	3.22	12.88	10.12	17.71
neuroblastoma cell line:NB-1	10539-107G8	12.16	18.90	20.39	27.13
neuroblastoma cell line:NBsusSR	10607-108F4	6.54	11.18	9.28	14.76
neuroblastoma cell line:NH-12	10555-107I6	9.69	22.36	13.60	13.60
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	2.37	9.25	11.39	16.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	3.01	11.40	19.01	18.06
neuroectodermal tumor cell line:TASK1	10774-110F9	7.65	16.30	21.53	15.30
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	0.00	7.63	10.17
neurofibroma cell line:Hs 53.T	10729-110A9	21.29	23.16	21.03	15.17
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	0.00	0.00	9.47	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1.86	4.40	8.46	17.59
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	2.40	4.80	15.21
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	26.61	17.95	13.14	15.07
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	22.07	16.82	13.93	11.30
nucleus accumbens, adult, pool1	10037-101F1	4.22	4.50	8.34	14.62
occipital cortex - adult, donor10196	10172-103C1	6.18	6.18	6.18	24.72
occipital cortex, adult, donor10252	10163-103B1	2.95	6.44	17.71	36.50
occipital cortex, newborn, donor10223	10355-105E4	4.00	3.28	8.01	9.83
occipital lobe, adult, donor1	10076-102A4	1.57	3.67	8.40	11.28
occipital lobe, fetal, donor1	10073-102A1	4.29	9.87	26.60	53.21
occipital pole, adult, pool1	10036-101E9	3.86	3.63	5.68	11.20
olfactory region, adult	10195-103E6	3.06	4.59	5.54	17.39
optic nerve, donor1	10277-104E7	0.00	4.00	16.01	14.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	36.91	27.11	13.21	12.53
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	6.05	13.05	11.40	5.50
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	5.08	10.50	14.22	5.93
oral squamous cell carcinoma cell line:SAS	10544-107H4	12.13	19.64	14.44	10.86
osteoclastoma cell line:Hs 706.T	10704-109H2	20.58	19.11	21.46	23.52
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	12.15	20.56	13.08	6.54
osteosarcoma cell line:HS-Os-1	10558-107I9	10.82	11.66	8.48	10.60
ovary, adult, pool1	10020-101D2	32.06	17.82	13.71	19.92
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	2.93	6.97	12.65	12.83
pancreas, adult, donor1	10049-101G4	12.23	19.75	4.70	11.29
pancreatic carcinoma cell line:NOR-P1	10698-109G5	12.30	15.93	8.39	12.58
papillary adenocarcinoma cell line:8505C	10437-106E5	56.05	44.46	27.09	17.89
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	6.79	7.45	7.12	8.61
paracentral gyrus, adult, pool1	10035-101E8	3.94	5.22	7.69	13.18
parietal cortex, adult, donor10258	10373-105G4	2.20	2.20	4.40	14.68
parietal lobe - adult, donor10196	10171-103B9	1.88	1.88	2.82	19.75
parietal lobe, adult, donor10252	10157-103A4	3.42	5.42	11.40	19.38
parietal lobe, adult, pool1	10034-101E7	3.88	5.02	7.84	15.69
parietal lobe, fetal, donor1	10072-101I9	2.91	6.79	13.58	50.43
parietal lobe, newborn, donor10223	10356-105E5	3.74	4.49	9.35	6.73
parotid gland, adult	10199-103F1	9.87	6.78	1.85	8.63
penis, adult	10200-103F2	34.38	13.96	19.34	16.11
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2.23	4.28	5.58	10.23
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	3.79	4.81	6.56	5.68
pineal gland - adult, donor10196	10179-103C8	3.87	3.23	7.10	11.61
pineal gland, adult, donor10252	10160-103A7	2.37	7.11	8.88	18.95
pineal gland, adult, donor10258	10377-105G8	3.14	2.51	6.27	9.41
pituitary gland - adult, donor10196	10180-103C9	14.17	9.11	7.08	18.21
pituitary gland, adult, donor10252	10162-103A9	6.78	8.86	24.50	26.06
pituitary gland, adult, donor10258	10378-105G9	11.92	5.11	5.11	11.07
placenta, adult, pool1	10021-101D3	55.47	34.83	16.34	14.94
plasma cell leukemia cell line:ARH-77	10840-111E3	2.25	3.97	4.90	8.74
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	28.95	25.06	23.66	37.20
pons, adult, pool1	10033-101E6	6.28	4.73	6.20	8.09
postcentral gyrus, adult, pool1	10032-101E5	3.75	4.01	6.19	12.81
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	4.18	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	5.97	4.52	4.81	2.48
prostate cancer cell line:PC-3	10439-106E7	10.71	15.06	13.07	13.07
prostate, adult, pool1	10022-101D4	20.50	11.70	9.98	16.69
putamen, adult, donor10196	10176-103C5	1.18	4.01	8.03	22.19
putamen, adult, donor10252	10152-102I8	0.00	1.96	7.84	13.73
putamen, adult, donor10258, tech_rep1	10372-105G3	2.19	1.09	4.37	9.84
putamen, adult, donor10258, tech_rep2	10372-105G3	1.93	1.93	6.04	12.32
putamen, newborn, donor10223	10365-105F5	6.75	8.25	5.25	7.50
rectal cancer cell line:TT1TKB	10469-106I1	8.44	7.56	3.49	4.07
rectum, fetal, donor1	10067-101I4	8.35	15.30	19.47	37.56
renal cell carcinoma cell line:OS-RC-2	10411-106B6	14.84	7.63	4.66	3.82
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	1.66	2.49	4.56	7.87
retina, adult, pool1	10030-101E3	19.38	11.13	11.13	16.00
retinoblastoma cell line:Y79	10475-106I7	5.98	11.17	7.27	3.64
rhabdomyosarcoma cell line:KYM-1	10787-110H4	5.66	9.84	8.61	4.18
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	4.78	12.37	8.72	3.94
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.91	12.13	10.61	12.88
salivary acinar cells, donor1	11771-123I7	17.64	26.87	23.47	12.30
salivary acinar cells, donor2	11772-123I8	40.07	54.94	36.49	15.97
salivary acinar cells, donor3	11773-123I9	33.10	35.09	19.86	17.88
salivary gland, adult, pool1	10093-102C3	10.30	4.00	7.44	12.01
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	18.72	12.56	15.93	12.48
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.99	10.46	12.81	17.28
seminal vesicle, adult	10201-103F3	14.28	13.23	10.05	7.94
serous adenocarcinoma cell line:JHOS-2	10639-108I9	16.76	16.52	9.47	7.77
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.08	8.56	6.79	14.09
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	13.05	11.04	4.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	17.19	20.95	13.03	6.04
signet ring carcinoma cell line:Kato III	10436-106E4	13.15	11.83	11.27	6.19
signet ring carcinoma cell line:NUGC-4	10483-107A6	20.90	18.97	14.19	9.03
skeletal muscle - soleus muscle, donor1	10282-104F3	25.54	20.57	17.73	19.15
skeletal muscle, adult, pool1	10023-101D5	19.07	8.40	7.20	13.79
skeletal muscle, fetal, donor1	10066-101I3	6.03	17.09	6.03	10.05
skin, adult, donor1	10074-102A2	6.79	27.14	27.14	20.36
skin, fetal, donor1	10065-101I2	18.31	27.77	31.56	35.35
small cell cervical cancer cell line:HCSC-1	10800-110I8	5.67	7.67	11.01	9.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	37.82	23.01	12.29	13.55
small cell lung carcinoma cell line:DMS 144	10841-111E4	5.20	10.99	10.99	20.82
small cell lung carcinoma cell line:LK-2	10541-107H1	5.27	3.30	6.92	6.92
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1.13	6.76	5.31	4.50
small cell lung carcinoma cell line:WA-hT	10562-108A4	12.20	16.34	11.11	26.37
small intestine, adult, pool1	10024-101D6	11.71	9.32	10.15	12.42
small intestine, fetal, donor1	10064-101I1	4.67	6.88	8.35	11.30
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	6.67	7.69	6.15	4.62
smooth muscle, adult, pool1	10048-101G3	22.49	16.28	15.51	32.05
somatostatinoma cell line:QGP-1	10781-110G7	4.02	8.58	11.52	14.74
spinal cord - adult, donor10196	10181-103D1	3.21	8.49	8.72	15.37
spinal cord, adult, donor10252	10159-103A6	4.73	5.13	7.49	23.26
spinal cord, adult, donor10258	10369-105F9	6.23	3.46	4.84	17.99
spinal cord, fetal, donor1	10056-101H2	10.37	15.25	9.15	14.64
spinal cord, newborn, donor10223	10359-105E8	13.78	14.69	11.94	17.45
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.40	20.01	19.42	16.43
spleen, adult, pool1	10025-101D7	8.26	6.06	7.38	11.56
spleen, fetal, pool1	10044-101F8	11.44	10.25	10.09	13.90
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	3.00	4.76	9.32	10.77
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	8.73	7.41	10.06	6.27
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	7.34	9.78	3.49	6.29
squamous cell carcinoma cell line:T3M-5	10616-108G4	16.03	17.20	16.81	8.99
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	13.06	12.49	8.22	7.65
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	2.12	5.51	6.78	7.62
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	44.85	48.65	46.11	47.81
stomach, fetal, donor1	10062-101H8	26.70	17.09	16.02	12.82
submaxillary gland, adult	10202-103F4	9.68	7.98	10.25	9.11
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	3.32	6.44	9.35	27.00
substantia nigra, adult, donor10258	10371-105G2	4.14	2.07	2.59	12.93
substantia nigra, newborn, donor10223	10358-105E7	11.31	6.36	10.60	9.89
synovial sarcoma cell line:HS-SY-II	10441-106E9	6.65	11.00	9.17	12.38
temporal lobe, adult, pool1	10031-101E4	4.32	3.73	9.41	11.36
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	0.71	14.25	28.49	56.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	3.96	8.35	13.19	18.90
tenocyte, donor1	11763-123H8	40.50	18.50	14.66	12.57
tenocyte, donor2	11765-123I1	70.96	27.47	11.83	19.08
tenocyte, donor3	11768-123I4	49.30	22.98	17.05	14.83
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	2.21	9.35	10.71	11.05
teratocarcinoma cell line:NCR-G1	10798-110I6	3.39	10.17	11.10	8.79
teratocarcinoma cell line:PA-1	10807-111A6	1.55	6.20	8.21	6.35
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1.90	7.11	15.11	18.28
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	3.78	11.35	15.88	11.35
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2.62	12.54	14.29	11.02
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1.95	7.49	8.14	13.68
testis, adult, pool1	10026-101D8	18.79	13.31	11.70	15.25
testis, adult, pool2	10096-102C6	12.18	10.37	8.12	17.14
thalamus - adult, donor10196	10168-103B6	2.21	2.21	4.42	17.66
thalamus, adult, donor10252	10154-103A1	2.81	4.84	10.00	24.69
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	0.00	3.08	10.78
thalamus, adult, donor10258, tech_rep2	10370-105G1	1.98	3.95	4.12	6.75
thalamus, newborn, donor10223	10366-105F6	3.45	6.90	6.90	5.75
throat, adult	10209-103G2	20.72	11.98	15.73	10.99
throat, fetal, donor1	10061-101H7	16.76	15.54	13.71	22.85
thymic carcinoma cell line:Ty-82	10803-111A2	9.54	9.74	12.72	7.55
thymus, adult, pool1	10027-101D9	1.89	2.19	4.97	16.01
thymus, fetal, pool1	10043-101F7	5.40	5.61	10.08	23.17
thyroid carcinoma cell line:KHM-5M	10776-110G2	8.38	6.91	7.45	5.98
thyroid carcinoma cell line:TCO-1	10783-110G9	24.31	39.53	46.38	27.10
thyroid, adult, pool1	10028-101E1	35.55	21.56	16.89	19.60
thyroid, fetal, donor1	10060-101H6	19.25	15.82	10.02	13.97
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	18.48	21.56	18.48
tongue, adult	10203-103F5	20.93	12.09	17.21	13.02
tongue, fetal, donor1	10059-101H5	20.89	19.70	24.04	30.35
tonsil, adult, pool1	10047-101G2	11.12	6.61	13.62	16.43
trachea, adult, pool1	10029-101E2	16.36	12.68	12.35	12.27
trachea, fetal, donor1	10058-101H4	25.77	30.01	14.23	22.70
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.45	21.97	21.61	15.23
transitional-cell carcinoma cell line:5637	10418-106C4	3.44	7.19	8.41	8.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	34.16	45.28	36.66	28.52
tridermal teratoma cell line:HGRT	10694-109G1	7.61	13.32	15.22	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	7.20	8.04	9.73	12.27
umbilical cord, fetal, donor1	10057-101H3	25.04	10.43	27.12	16.69
uterus, adult, pool1	10100-102D1	58.70	24.74	35.49	33.78
uterus, fetal, donor1	10055-101H1	16.89	25.08	20.99	24.57
vagina, adult	10204-103F6	20.68	7.75	17.45	20.03
vein, adult	10191-103E2	16.22	8.33	11.18	16.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.53	2.40	2.94	13.35